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1. SUMMARY 
 
Germline inactivation of the mineralocorticoid receptor (MR) gene in mice results in early 
postnatal lethality due to massive loss of sodium and water associated with impaired epithelial 
sodium channel (ENaC) activity in kidney and colon. The aim of the present study was the 
analysis of the role of renal principal cell MR, which is activated by aldosterone, in ENaC-
mediated sodium reabsorption. For this purpose, mice deficient for MR in ENaC-expressing 
renal principal cells were generated using the Cre-loxP recombination system. A large fragment 
of genomic mouse DNA harbouring 156 kb of the aquaporin 2 (AQP2) gene was used to drive 
the expression of Cre recombinase in principal cells (AQP2Cre mice). Mice carrying a 
conditional MR allele were crossed with AQP2Cre mice to obtain mutant (MRAQP2Cre) mice. 
MRAQP2Cre mice developped normally under standard diet and exhibited unaltered renal sodium 
excretion, but strongly elevated plasma aldosterone levels. When challenged with a low-sodium 
diet, MRAQP2Cre mice showed increased renal sodium and water excretion resulting in a 
continuous loss of bodyweight. Immunofluorescence for MR and αENaC staining revealed that 
the loss of MR expression is restricted to principal cells of the collecting duct (CD) and late 
connecting tubule (CNT), and that MR is crucial for apical αENaC trafficking to the apical 
membrane. The early CNT that accounts for about 30% of the CNT was not targeted. 
Determination of the fractional excretion of sodium before and after treatment with the ENaC 
blocker amiloride showed that renal ENaC activity in the mutant mice was preserved. These data 
demonstrate that the late distal convoluted tubule (DCT) and early CNT, which were not targeted 
in MRAQP2Cre mice, can compensate to a large extent impaired ENaC-mediated sodium 
reabsorption in the late CNT and CD.  
To overcome a possible postnatal lethality of the MRAQP2Cre mice, an inducible principal cell-
specific gene inactivation system was established in parallel to induce MR inactivation in adult 
mice. The large genomic DNA fragment harbouring the AQP2 gene, used for the generation of 
the constitutive AQP2Cre transgene, was also used to drive the expression of the tamoxifen-
inducible CreERT2 fusion protein (AQP2CreERT2 mice). Three AQP2CreERT2 transgenic lines 
containing 1, 4 and 9 copies of the transgene respectively were established and showed 
tamoxifen-induced recombination in most of the renal principal cells, but leakiness of the fusion 
protein in the papilla region of the kidney. 
To identify aldosterone-regulated genes potentially involved in the control of ENaC-mediated 
renal sodium reabsorption, gene expression profiling using microarrays was performed on a 
mouse renal cortical CD principal cell line (mpkCCDc14) in the presence or absence of 
aldosterone. Quantitative RT-PCR for the identified candidates on microdissected CDs from 
control mice fed with standard or low-sodium diet confirmed the induction by aldosterone of the 
genes encoding the serum- and glucocorticoid-regulated kinase 1 (Sgk1) and the ubiquitin-
specific protease 2 (Usp2). Quantitative RT-PCR on microdissected CDs from control mice and 
principal cell MR-deficient (MRAQP2Cre) mice under low-sodium diet showed that the gene 
expression levels of Sgk1 and the serine/threonine protein kinase 3 (Pim3) were reduced in the 
mutant mice. Thus, these data identified Pim3 as a new MR-regulated gene involved in the 
control of ENaC-mediated sodium reabsorption.  
                      Zusammenfassung 
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1. ZUSAMMENFASSUNG 
 
Die Keimbahninaktivierung des Mineralokortikoidrezeptor-(MR)-Gens in Mäusen führt infolge 
eines massiven Verlusts von Natrium und Wasser zu Lethalität in der zweiten Woche nach der 
Geburt. Der Natrium/Wasser-Verlust geht einher mit einer gestörten Aktivität des epithelialen 
Natriumkanals (ENaC) in der Niere und im Kolon. Ziel der vorliegenden Arbeit ist es, die Rolle 
des MR in Aldosteron-aktivierten Hauptzellen des distalen Nierenepithels bei der Natrium-
Rückresorption durch ENaC zu klären. Dazu wurden mit Hilfe des Cre-loxP-
Rekombinationssystems Mäuse hergestellt, bei denen der MR in den Hauptzellen der Niere 
inaktiviert ist. Zur Expression der Cre-Rekombinase in Hauptzellen wurde ein 156 kB-großes 
Fragment genomischer Maus-DNA, das die regulatorischen Elemente des Aquaporin 2-Gens 
enthält, verwendet (AQP2Cre Mäuse). Zur Erzeugung von MR-defizienten Mäusen (MRAQP2Cre), 
wurden Mäuse mit einem konditionalen MR-Allel und AQP2Cre-Mäuse gekreuzt. Unter 
Standarddiät entwickelten sich MRAQP2Cre-Mäuse normal, ihre Natrium-Ausscheidung war nicht 
verändert, aber sie hatten stark erhöhte Aldosteron-Spiegel im Plasma. Bei Gabe vom Natrium-
armen Futter zeigten MRAQP2Cre-Mäuse eine erhöhte renale Natriumausscheidung einhergehend 
mit erhöhter Urinproduktion, was zu einem kontinuierlichen Gewichtsverlust führte. Färbungen 
für MR und αENaC mittels Immunfluoreszenz zeigte einen Verlust des MR und der apikalen 
ENaC Expression selektiv in den Hauptzellen der Sammelrohre (CD) und den distalen Bereich 
der Verbindungsstücke (CNT). Der proximale Bereich des CNT, der etwa 30% der gesamten 
CNT ausmacht, war nicht von der Germinaktivierung betroffen. Eine Bestimmung der 
fraktionellen Natriumausscheidung vor und nach Behandlung mit dem ENaC-Blocker Amilorid 
ergab, dass die ENaC-Aktivität in der Niere insgesamt unverändert war. Diese Daten zeigen, 
dass in MRAQP2Cre Mäusen der Verlust des MR im distalen CNT und CD weitgehend 
kompensiert werden kann durch den distalen Konvolut (DCT) und den proximalen CNT, welche 
den MR weiterhin exprimieren. 
Um eine mögliche Lethalität der konstitutiven Inaktivierung des MR-Gens in den Hauptzellen 
des distalen Nierenepithels umgehen zu können, wurden parallel Mäuse mit einer induzierbaren 
MR-Inaktivierung hergestellt. Das selbe genomische Fragment, das für die Herstellung der 
AQP2Cre-Mäuse verwendet worden war, wurde zur Expression eines durch Tamoxifen-
induzierbaren CreERT2-Fusionsproteins und zur Herstellung von AQP2CreERT2-Mäusen benutzt. 
Es wurden drei AQP2CreERT2-transgene Linien mit 1, 4 oder 9 Kopien erzeugt. Alle zeigten 
Tamoxifen-abhängige Rekombination, aber das Fusionsprotein wurde auch ohne Tamoxifen-
Gabe in der Nierenpapille aktiviert. 
Zur Identifizierung von Aldosteron-regulierten Genen, die an der Kontrolle der Natrium-
Rückresorption durch ENaC beteiligt sind, wurde eine Expressionsanalyse durch Hybridisierung 
von RNA aus einer Maus-Hauptzelllinie (mpkCCDc14) an DNA-Mikroarrays durchgeführt. Die 
mpkCCDc14-Zellen waren mit Aldosteron bzw. Vehikel behandelt. Die auf diese Weise 
gefundenen Kandidatengene wurden mittels quantitativer RT-PCR von RNA, die aus 
mikrodissezierten CD von Kontroll-Mäusen nach Standard- oder Natrium-armen Futter isoliert 
worden war, verifiziert. Auf diese Weise wurde die Induzierbarkeit der Serum- und 
Glukokortikoid-regulierten Kinase 1 (Sgk1) und der Ubiquitin-spezifische Protease 2 (Usp2) 
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durch Aldosteron in vivo nachgewiesen. Quantitative RT-PCR von RNA am mikrodissezierten 
CD von Kontrollmäusen und von Mäusen mit einer selektiven MR-Mutation in Hauptzellen des 
distalen Nierenepithels (MRAQP2Cre), die unter Natrium-armen Futter gehalten wurden, zeigte 
eine verringerte Expression von Sgk1 und der Serine/Threonine Protein Kinase 3 (Pim3). Diese 
Expressionsdaten identifizieren Pim3 als neues MR-reguliertes Gen, das möglicherweise an der 
Kontrolle der ENaC-abhängigen Natrium-Rückresorption beteiligt ist. 
  Introduction  
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2. INTRODUCTION 
 
2.1. The mineralocorticoid aldosterone  
 
Fluid and electrolyte regulation is essential for homeostasis. If water or electrolyte levels rise or 
fall beyond normal limits, many functions of the body fail to proceed at their normal rates. The 
mineralocorticoids are so named for their role in the regulation of minerals, sodium and 
potassium metabolism. Aldosterone is the principal physiological mineralocorticoid and plays a 
major role in the control of sodium balance, fluid homeostasis and blood pressure by regulation 
of transepithelial sodium transport.  
Aldosterone is a steroid hormone and is synthesized from cholesterol in the zona glomerulosa of 
the adrenal cortex by a series of enzymatic reactions catalyzed by dehydrogenases and mixed-
function oxidases, many of which belonging to the cytochrome P450 enzyme superfamily (1). 
Aldosterone biosynthesis is regulated principally by extracellular potassium concentration and 
plasma angiotensin II levels. Small increase in extracellular potassium concentration acutely 
induces the production of aldosterone (2). The action of angiotensin II on aldosterone involves a 
negative-feedback loop, called the renin-angiotensin-aldosterone system (RAAS) that also 
includes sodium delivery and extracellular fluid volume. The major function of this feedback 
loop is to modify sodium homeostasis and, secondarily, to regulate arterial pressure (3, 4). Thus, 
sodium restriction sensed by the macula densa, a specialized group of renal cells that function as 
chemoreceptors for monitoring tubular sodium concentration, and low blood pressure both 
activate the synthesis of the renin enzyme by the juxtaglomerular cells of the renal cortex. Renin 
is secreted into the blood and cleaves its substrate, angiotensinogen, which is synthesized by the 
liver, to produce the decapeptide angiotensin I. Angiotensin I is rapidly cleaved by the 
angiotensin-converting enzyme (ACE) in the lung and other tissues to form the octapeptide 
angiotensin II that leads to vasoconstriction and aldosterone secretion (Figure 1). The effects of 
angiotensin II on both the adrenal cortex and the renal vasculature promote renal conservation. 
Conversely, with suppression of renin release and suppression of the level of circulating 
angiotensin II, aldosterone secretion is reduced, and renal blood flow is increased, thereby 
promoting reduced sodium reabsorption.  
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Figure 1. Renin-angiotensin-aldosterone and potassium-aldosterone negative-feedback loops. Aldosterone 
production is determined by input from each loop. ACE: angiotensin-converting enzyme. 
 
 
2.2. The mineralocorticoid receptor  
 
2.2.1. A member of the nuclear receptor family 
 
The classical way of action of aldosterone on target cells to regulate electrolyte and fluid balance 
is through binding to the mineralocorticoid receptor (MR). MR belongs to the nuclear receptor 
(NR) superfamily, which also includes receptors for thyroid and steroid hormones, vitamin D3, 
and retinoic acids, as well as numerous orphan receptors for which no ligands are known (5-8). 
Within the NR superfamily, MR belongs to the steroid receptor subfamily, together with the 
glucocorticoid receptor (GR), the androgen receptor (AR), the progesterone receptor (PR) and 
the estrogen receptor (ER).  
NRs are ligand-activated transcription factors that modulate target gene transcription and contain 
five characteristic major domains. The amino-terminal domain (also called A/B region), which is 
of variable length and sequence in the different NR family members, contains several functional 
domains responsible for ligand-independent activation. The central highly conserved DNA-
binding domain (DBD) (or C region) is reponsible for DNA binding and receptor dimerization. 
The hydrophilic hinge (D region) between the DBD and the carboxy-terminal domain contains 
the nuclear localization signal (NLS). The carboxy-terminal domain (E region) mediates 
numerous functions, including ligand binding, interaction with heat-shock proteins and 
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transcriptional coactivators, dimerization, nuclear targeting, and hormone-dependent activation. 
It contains the ligand-binding domain (LBD), which is well conserved between the various NR 
family members but diverges sufficiently to guarantee selective ligand recognition (5-9). The 
mouse MR gene (NR3C2), localized to chromosome 4, spans over approximately 450 kb and 
contains ten exons (10). The two first exons 1, referred to 1α and 1β, are untranslated, whereas 
the eight other exons (exon 2 - 9) encode the protein with the five domains (from A to E) 
characteristic for the NRs (Figure 2). MR and GR show 15% of homology for the amino-
terminal A/B region, 94% for the DBD and 57% for the LBD.  
Ligand-dependent MR activation resulting in regulation of gene transcription is a multistep 
process characteristic for NRs. Binding of the ligand to MR causes a conformational change 
within the LBD that leads to the dissociation of the associated heat shock proteins from the 
receptor, thus unmasking the NLS sequence responsible for nuclear translocation (11, 12). The 
ligand-activated receptor then binds as a dimer to a palindromic sequence 
(CGZACAANNTGTYCTK) located in the promoter region of MR target genes, and activates or 
represses their transcription (13). When MR is activated by aldosterone, the MR target genes are 
called aldosterone-induced or aldosterone-repressed transcripts (AITs and ARTs, respectively) 
(11, 14, 15). The palindromic sequence is recognized not only by MR but also by GR and AR 
and is called glucocorticoid response element (GRE) as it was first detected as the target 
sequence for the GR.  
 
 
 
Figure 2. Schematic representation of the MR gene (A) and the structural organization of the encoded protein 
(B) with the five functional regions. Exons and the corresponding encoded protein domains (domains A-E) are 
indicated by colours boxes. NTD: N-terminal domain; DBD: DNA-binding domain; LBD: ligand-binding domain. 
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2.2.2. Ligand binding specificity 
 
The cloning of GR (16) as well as of MR (17) allowed an unequivocal comparison of their 
expression patterns as well as of their affinities to gluco- and mineralocorticoids. In contrast to 
GR, which is expressed in most if not all cells, MR expression is restricted to the limbic system 
of the brain, to the heart, and to epithelial cells that line the distal part of the nephron, the distal 
colon, and the ducts of several exocrine glands (18-20). An important finding that issued from 
the cloning of the MR cDNA and expression of the MR protein is that the receptor is not 
selective for aldosterone. The MR binds the glucocorticoid cortisol (corticosterone in rodents) 
with a 10-fold higher affinity (dissociation constant: Kd = 0.5–2 nM) than the GR (Kd = 10-60 
nM) and, in addition, the mineralocorticoid aldosterone with equal affinity (21). Since the 
concentration of corticosterone in the plasma is 100- to 1000-fold higher than that of aldosterone, 
and since MR has the same affinity for cortisol as for aldosterone, corticosterone should 
permanently occupy MR, precluding any regulatory role of aldosterone. It was shown that the 
specificity of aldosterone for MR in aldosterone target cells in vivo is given by a prereceptor 
mechanism, which converts corticosterone into receptor-inactive 11-dehydrocorticosterone (22, 
23). The prereceptor mechanism found to protect MR from corticosterone, thus enabling 
aldosterone to interact with MR, is mediated by the enzyme 11β-hydroxysteroid dehydrogenase 
type 2 (11β-HSD2). Thus, in cells coexpressing MR and 11β-HSD2, namely epithelial cells from 
the distal nephron, the distal colon, and the ducts of sweat and salivary glands (24-26), 
permanent occupancy of MR by glucocorticoid hormones is largely prevented, allowing 
concentration-dependent binding of aldosterone to MR. The important role of 11β-HSD2 in MR 
binding selectivity is highlighted by the loss-of-function mutations in the 11β-HSD2 locus, 
identified in the syndrome of apparent mineralocorticoid excess (AME). Patients suffering from 
AME display severe hypertension, sodium retention and urinary potassium loss but very low 
levels of plasma aldosterone (27). 
 
2.2.3. MR mutations and MR knockout mice 
 
In humans, different MR loss-of-function mutations like missense, frameshift and nonsense 
mutations have been identified, which are localized in all exons of the MR gene. These 
mutations either change the conformation of the ligand-binding pocket and impair ligand 
binding, or generate premature termination codons and truncated proteins. All these MR 
mutations result in a syndrome of mineralocorticoid resistance called autosomal 
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pseudohypoaldosteronism type 1 (PHA1), characterized by renal salt wasting, dehydration, high 
plasma aldosterone levels and severe hyperkalemic acidosis (28).  
To gain new insights into MR function in vivo, mice with a null mutation in the MR gene were 
generated (29). MR knockout mice died in the second week after birth due to severe loss of 
sodium and water, and showed symptoms similar to PHA1 (28). The effect of amiloride on renal 
sodium excretion and colonic transpithelial voltage showed that the activity of the amiloride-
sensitive epithelial sodium channel (ENaC) and thereby sodium reabsorption was strongly 
impaired in kidney and colon in MR knockout mice. These mutant mice could be rescued by 
daily injection of an isotonic sodium-chloride solution, showing that the loss of sodium and 
water is the cause of lethality (30, 31). The severe salt-wasting phenotype of MR knockout mice 
demonstrates the central role of MR in the control of sodium and volume balance. In addition, 
the impaired renal sodium reabsorption in these mice suggests that the main site of MR action to 
control sodium balance is located in the aldosterone-sensitive part of the kidney. 
 
2.3. Renal control of sodium and water balance 
 
2.3.1. The kidney  
 
The kidney plays a major role in the homeostasis of body fluid compartments in mammals (32). 
Despite the large quantitative variations in dietary intake of solutes and water, the kidneys are 
able to maintain within a narrow range the composition and volume of extracellular and 
intracellular fluid compartments. The kidney is made of three distinct regions: the pelvis, the 
medulla and the cortex. The renal pelvis is a large urine-collecting space formed from the 
expanded upper portion of the ureter. The renal medulla is the middle portion of the kidney. It 
contains 8 to 18 renal pyramids, which consist of tubules and collecting ducts (CDs) and which 
end in the renal pelvis. Urine passes from CDs in the pyramids to the renal pelvis, then into the 
ureter and is transported to the urinary bladder. The renal cortex is the outermost portion of the 
kidney and contains capillaries and glomeruli of the nephrons, the functional units of the kidney. 
The cortical tissue that penetrates the renal medulla between the renal pyramids forms the 
medullary rays, which contains the thick descending limb, the Henle loop, the distal nephron 
tubules and the CDs. 
The nephron consists of a U-shaped tubular component and an associated vascular component. 
The tubular component starts with the glomerular (Bowman´s) capsule and includes the 
excretory tubules, which are the proximal convoluted tubule, the thick descending limb, the 
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Henle loop, the thick ascending limb (TAL), the distal convoluted tubule (DCT) and the 
connecting tubule (CNT). Each excretory tubules leads into a large collecting duct (CD) (whose 
cortical part only belongs to the nephron) that transports the resulting renal filtrate (Figures 3A 
and 3B). Each kidney contains about one million of nephrons. 
The kidney separates the molecules that will be excreted from the body as urine (through the 
ureter to the bladder) from those that will be returned to the circulating blood (through the renal 
vein) via three different processes: filtration, reabsorption, and secretion. The blood filtered by 
the kidney flows from the afferent arteriole into the glomerulus under a high pressure. This 
pressure forces some of the blood plasma into the glomerular capsule, but the blood cells and 
large proteins remain within the blood circulation, unable to pass through the endothelial 
capsular membrane. This process is called glomerular filtration and forms the initial urine called 
glomerular filtrate. As the glomerular filtrate passes through the length of the nephron tubule, 
useful substances like water, sodium ions, glucose and amino acids that were initially lost from 
the blood during filtration are returned to the blood by active and passive transport. This process 
is called tubular reabsorption. Some unwanted ions and substances may be transported from the 
blood in the peritubular capillaries into the glomerular filtrate as it passes through the nephron 
tubules. In this way, products such as potassium ions, hydrogen ions, certain drugs, and organic 
compounds may be excreted. This process is called tubular secretion and occurs in a direction 
opposite to that of tubular reabsorption. Finally, the glomerular filtrate moves to the medulla of 
the kidney, where it is now called urine, and passes to the bladder through the ureter. 
 
2.3.2. The aldosterone-sensitive distal nephron (ASDN) 
 
Aldosterone regulation of sodium reabsorption in kidney is restricted to a part of the distal 
nephron called the aldosterone-sensitive distal nephron (ASDN). The distal nephron of the 
mammalian kidney, which reabsorbs in humans 5% to 10% (0.5% to 1% in mice) of the filtered 
sodium under normal conditions, is defined as the nephron segment interposed between the 
macula densa region, a portion of the renal distal tubule in contact with the afferent arterioles, 
and the end part of the cortical CD upstream its confluence with another nephron. The distal 
nephron can be divided into successive portions, which are formed to adapt to the function of 
fine adjustments of sodium balance and which is reflected by an axial heterogeneity in protein 
expression (33, 34). The distal nephron comprises the TAL, the DCT, the CNT and the cortical 
CD. The ASDN is restricted to the segments of the distal nephron where MR and 11β-HSD2 are 
coexpressed: the late DCT, the CNT and the cortical CD (Figure 3C).  
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Figure 3. The kidney and the nephron. A: Entire kidney. B: Structure of the nephron and nomenclature of the 
different tubular segments. The red rectangle indicates the localization of the macula densa (MD) region. C: 
Schematic distribution of AQP2, ENaC, 11β-HSD2, MR and TSC protein expression along the different segments 
of the distal nephron in mice. AQP2: water channel aquaporin 2; ASDN: aldosterone-sensitive distal nephron; 
ENaC: epithelial sodium channel; MR: mineralocorticoid receptor; TSC: thiazide-sensitive sodium-chloride 
cotransporter; 11β-HSD2: 11β-hydroxysteroid dehydrogenase type 2. 
 
Whereas the DCT and CNT are composed mainly of one type of epithelial cells, the CD consists 
of two different cell types, principal cells and intercalated cells, which exhibit profound 
morphological differences and serve markedly different functions (35, 36). The principal cells 
mediate sodium and water reabsorption, whereas the intercalated cells are responsible for proton 
transport (25). The CD and the different segments of the distal nephron have been defined 
according to the expression of specific transport proteins responsible for transepithelial ion 
movement from the tubular lumen to the interstitium (37). The DCT is characterized by the 
expression of the thiazide-sensitive sodium-chloride cotransporter (TSC, also termed NCC), 
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which is expressed in the more proximal part (early DCT) as well as in the distal part (late DCT) 
of the DCT. In the late DCT, the TSC is colocalized with the amiloride-sensitive epithelial 
sodium channel (ENaC). In the principal cells of the CNT and CD, ENaC is colocalized with 
MR and the apical water channel aquaporin 2 (AQP2) (29, 38-41) (Figure 3C). 
 
2.4. Regulation of renal transepithelial sodium reabsorption 
by aldosterone 
 
2.4.1. The epithelial sodium channel (ENaC) 
 
Aldosterone controls the fine adjustments of sodium balance by acting on MR expressed in the 
ASDN (42). The main target for aldosterone action is the epithelial sodium channel (ENaC) 
responsible for apical sodium entry.  
ENaC is a heteromultimeric ion channel located in the apical membrane of sodium-transporting 
epithelial cells. In addition to principal cells of the distal nephron, ENaC is also expressed in 
other aldosterone-responsive sites like the distal colon, the ducts of the sweat and the salivary 
glands. ENaC is also expressed in the airway epithelium from the nose to distal bronchiolar 
epithelium and in alveolar epithelial cells where its regulation is mediated by glucocorticoids 
(43). The activity of ENaC is the rate-limiting step for epithelial sodium reabsorption and is 
inhibited by the diuretic amiloride at submicromolar concentrations (44).  
ENaC is composed of three different subunits (α, β and γENaC) in the ratio 2:1:1, which are 
encoded by three different genes (45). All the three subunits are necessary for maximal ENaC 
activity (45-47). However, heterologous expression of single ENaC subunits in Xenopus oocytes 
revealed that expression of αENaC is sufficient to generate a sodium current (48), but that 
βENaC and γENaC greatly potentiate sodium current when coexpressed with αENaC (49).  
The importance of ENaC function in sodium homeostasis is highlighted by human genetic 
diseases caused by spontaneous mutations in the genes encoding the ENaC subunits. Gain-of-
function mutations of βENaC or γENaC lead to increased ENaC activity and cause Liddle's 
syndrome, characterized by volume expansion and hypokalemic alkalosis (50, 51). Homozygous 
loss-of-function mutations of αENaC, βENaC and γENaC lead to PHA1 (52, 53). Gene targeting 
in mice confirmed the crucial role of the three ENaC subunits for sodium homeostasis (54). In 
addition, the strongly impaired renal ENaC activity together with the loss of sodium and water 
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observed in MR knockout mice suggest the importance of principal cell MR in the control of 
ENaC-mediated sodium reabsorption. 
 
2.4.2. Regulation of ENaC-mediated renal sodium reabsorption 
by aldosterone  
 
Epithelial cell layers separate compartments of distinct compositions. In order to maintain a 
constant ionic equilibrium, epithelial cells regulate transfer of water and solutes between them 
with extreme precision (55). The interstitium compartment, in equilibrium with the blood, is 
characterized by the constancy of its composition. In contrast, the composition of the luminal 
compartment varies greatly from one epithelium to another and with time. Epithelial cells are 
characterized by their functional polarization, since their apical membrane facing the luminal 
compartment has receptors as well as transport and permeability properties distinct from their 
basolateral membrane bathed in the interstitium compartment. Sodium as well as potassium and 
chloride transport is accompanied by a parallel movement of water.  
In aldosterone-sensitive renal principal cells, aldosterone modulates the reabsorption of sodium 
by regulating sodium entry via ENaC across the apical membrane, the primary determinant of 
the intracellular sodium concentration in these cells. In turn, the intracellular sodium 
concentration directly controls the activity of the sodium-potassium-ATPase (Na+-K+-ATPase) 
responsible for sodium extrusion across the basolateral membrane (56) (Figure 4). Therefore, 
apical ENaC-mediated sodium entry is limiting for transepithelial sodium and fluid transport, 
and any change in the quantity and/or activity of ENaC are important steps in the regulation of 
sodium reabsorption by aldosterone (57).  
Several studies using candidate gene approaches (58, 59) or unbiased screens (60-64) have been 
undertaken to detect the mechanistic basis of aldosterone action on ENaC-mediated sodium 
reabsorption. As with other steroid hormone-regulated processes (65), two major classes of target 
genes have been identified: early and late. Early regulated genes appear to be required for 
initiation of the aldosterone response, whereas the late regulated genes are believed to participate 
in consolidation of the response (66). The latter include components of the ion transport 
machinery itself (for example, ENaC and Na+-K+-ATPase subunits) and genes that encode 
regulatory proteins that likely act to limit the extent of the aldosterone response (67). The former 
category (early aldosterone-regulated genes) encodes primarily signaling molecules, implicated 
in pathways that control ENaC activity and/or trafficking (57). The best characterized of these 
targets is the serum- and glucocorticoid-induced kinase 1 (SGK1) (57), which acts to increase 
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apical membrane ENaC, at least in part, by inhibiting the ubiquitin ligase Nedd4-2 by recruiting 
the 14-3-3 proteins and thus leading to modulation of ENaC trafficking and degradation (68, 69). 
Recently, several lines of evidence argue that aldosterone-regulated mediators other than SGK1 
are also required for early ENaC activation (57). Most notably, although SGK1 knockout mice 
have aldosterone resistance, their phenotype is substantially less severe than that of either MR or 
ENaC knockout mice (57, 70) or of adrenalectomized wild-type animals (71), suggesting that 
renal ENaC function and renal mineralocorticoid action are only partially dependent on SGK1 
and that aldosterone may act through multiple pathways to stimulate ENaC-mediated sodium 
reabsorption. 
 
Figure 4. Cellular mechanism of transepithelial sodium and water transport in renal principal cells of the 
collecting duct. Sodium reabsorption in principal cells is mediated by Na+-K+-ATPase at the basolateral membrane 
and by ENaC at the apical membrane. Aldosterone binds to MR, which then translocates into the nucleus, regulates 
the transcription of target genes and leads to increased ENaC-mediated sodium reabsorption. Arrows indicate net 
fluxes of ions and water. AIP: aldosterone-induced proteins; ARP: aldosterone-repressed proteins; ENaC: epithelial 
sodium channel; GRE: glucocorticoid response element; MR: mineralocorticoid receptor. 
 
 
In renal principal cells, potassium, chloride and water transport is coupled with sodium 
reabsorption (Figure 4). The apical sodium entry leads to a depolarization of the apical 
membrane and apical extrusion of potassium is therefore favoured in order to achieve 
repolarization (72). In addition, the stoichiometry of the basolateral Na+-K+-ATPase-mediated 
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sodium and potassium transport (entry of 3 sodium cations and exit of 2 potassium cations) 
generates a cation desequilibrium. Electroneutral transepithelial sodium reabsorption in the 
collecting duct principal cells is achieved through a passive diffusion of chloride anions via a 
paracellular pathway across the tight-junctions from the tubular lumen to the interstitium, and via 
reabsorption through transporters or exchangers in the intercalated cells (73). The net movement 
of sodium-chloride drives water flow, which is mediated by water channels, aquaporin 2 in the 
apical membrane and aquaporins 3 and 4 in the basolateral membrane (74). 
 
2.5. Conditional somatic mutagenesis in mice using the Cre-
loxP recombination system  
 
Gene targeting is one of the most powerful techniques to investigate the in vivo function of a 
gene product (75). However, knockouts may have disadvantages, e.g. the mutations may give 
rise to an embryonic or early postnatal lethal phenotype, thus precluding analysis of gene 
function in adult mice, and the problem of possible compensatory effects during development in 
mice containing the mutation. Furthermore, interpretation of a phenotype can be complicated by 
pleiotropic effects in many organs or tissues. To circumvent these problems, a strategy for 
conditional gene inactivation in a tissue-specific manner was developed using the Cre-loxP 
recombination system in mice (76). The Cre recombinase, encoded by the Cre gene of the 
bacteriophage P1, efficiently excises intervening DNA sequences located between two loxP sites 
in the same orientation (77, 78). For the application of gene targeting in mice, two transgenic 
mouse lines are necessary: one line expressing the Cre recombinase as a transgene under the 
control of a cell- or tissue-specific promoter (Cre line), and one line in which an essential exon 
of the gene of interest is flanked by two loxP sites (floxed allele). In mutant mice that are 
homozygous for the floxed allele and heterozygous for the Cre transgene, the gene of interest is 
inactivated (Figure 5).  
Since some promoters give already expression during pre- and postnatal development, the gene 
of interest will be inactivated before adulthood, and this could result in early lethality. To 
overcome this problem, an inducible ligand-activated recombination system has been established 
that can be used to induce recombination in adulthood (79-81). This system is based on the 
fusion of the Cre recombinase with a mutated ligand-binding domain (LBD) of the human 
estrogen receptor ER (CreERT2). The ER-LBD contains a nuclear localization signal that is 
unmasked upon ligand binding. Two point mutations in the ER-LBD allow binding of the 
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synthetic ligand tamoxifen and prevent activation of the CreERT2 by the endogenous estradiol. 
Therefore, the unliganded form of the CreERT2 fusion protein resides in the cytoplasm and 
translocates to the nucleus only upon tamoxifen binding, thus mediating site-specific 
recombination resulting in the tamoxifen-dependent gene inactivation.  
Figure 5. Constitutive tissue-specific gene inactivation in the mouse using the Cre-loxP recombination system. 
Breeding of a mouse expressing the Cre recombinase under the control of a tissue-specific promoter with a mouse 
harbouring a loxP-flanked exon of the gene to inactivate results in mice carrying both genetic modifications. Active 
Cre recombinase will excise the loxP-flanked DNA sequence in the cells of the targeted tissue, thereby inactivating 
the gene in these cells. 
 
 
2.6. Aims of the present study  
 
The severe salt-wasting phenotype of MR knockout mice demonstrated the importance of MR in 
the control of sodium balance. In addition, the impaired renal ENaC activity in these mice 
suggested that the main site of MR action to control sodium balance is located in the renal 
ENaC-expressing principal cells (29). To further investigate this hypothesis, the main aim of the 
present study was the  
 
“Analysis of the role of MR in renal principal cell ENaC-mediated sodium 
reabsorption in vivo”.  
 
To this end, mice lacking MR in renal principal cells were generated using the Cre-loxP 
recombination system. To drive the expression of the Cre recombinase, a PAC-derived large 
Cre recombinase
loxP site 
matings ExonPromoter Cre
Mutants
All other cell types 
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Exon
Excision
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genomic DNA fragment containing the regulatory elements of the mouse AQP2 gene was used, 
since AQP2 is coexpressed with ENaC in principal cells of the collecting duct and connecting 
tubule already during development (40). AQP2Cre transgenic mice were bred with mice carrying 
a conditional MR allele (82) to generate mutant (MRAQP2Cre) mice. 
Since the prenatal constitutive inactivation of renal principal cell MR could result in a very 
strong phenotype that may even lead to lethality, an inducible renal principal cell-specific gene 
inactivation system was established in parallel in order to induce MR inactivation in adulthood 
only.  
To identify MR-regulated genes involved in the control of ENaC-mediated sodium reabsorption 
in collecting duct principal cells upon aldosterone induction, gene expression profiling using 
microarrays was performed on a mouse collecting duct principal cell line treated with 
aldosterone or vehicle. The expression of aldosterone-regulated genes potentially involved in 
ENaC regulation was analyzed in microdissected collecting ducts from control and MRAQP2Cre 
mice. 
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3. RESULTS 
 
3.1. Renal principal cell-specific MR inactivation in the 
mouse 
 
Mice deficient for MR in renal principal cells were generated using the Cre-loxP recombination 
system. Transgenic mice expressing the Cre recombinase under the control of the regulatory 
elements of the mouse AQP2 gene (AQP2Cre mice) were generated and crossed with mice 
harboring a conditional MR allele generated previously (82), in which exon 3 encoding the first 
zinc finger of the MR DNA-binding domain was flanked by two loxP sites. For inactivation of 
MR-regulated sodium reabsorption mediated by ENaC in principal cells, the AQP2 promoter 
was chosen to drive the expression of the Cre recombinase in principal cells of the CD and CNT 
(Figure 6).  
 
Figure 6. The regulatory elements of the mouse AQP2 gene were used to drive the expression of the Cre 
recombinase in ENaC-expressing principal cells of the connecting tubule (CNT) and collecting duct (CD). A: 
AQP2Cre transgene: a PAC harboring 125 kb of the 5´upstream region and 31 kb of the 3´upstream region of the 
mouse AQP2 gene was modified by homologous recombination in bacteria to insert a cassette encoding Cre 
recombinase at the ATG of the AQP2 gene. HR: homology region. B: Schematic distribution of AQP2, ENaC, 11β-
HSD2, MR and TSC protein expression along the distal tubular segments of the nephron. The regulatory elements of 
the mouse AQP2 gene were used to drive Cre recombinase expression in ENaC-expressing principal cells of the 
CNT and CD. AQP2: water channel aquaporin 2; CD: collecting duct; CNT: connecting tubule; DCT: distal 
convoluted tubule; ENaC: epithelial sodium channel; MR: mineralocorticoid receptor; TSC: thiazide-sensitive 
sodium-chloride cotransporter; 11β-HSD2: 11β-hydroxysteroid dehydrogenase type 2. 
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3.1.1. Generation of mice lacking MR in renal principal cells  
 
3.1.1.1. Generation of AQP2Cre transgenic mice 
A mouse genomic PAC library (RPCI21, RZPD, Germany) was screened with a probe for the 
AQP2 gene as described in the Materials and Methods part. Three PACs containing a genomic 
DNA fragment of 156 kb, 118 kb and 97 kb respectively were isolated and characterized by 
sequencing the ends of the genomic insert. The respective sequences were then blasted to the 
mouse genome (www.ensembl.org) to determine the position of the start codon of the AQP2 
locus on the PACs, the position of exons and introns, and the length of the 5´ and 3´ regions. A 
PAC with a 5´ region bigger than the 3´ region, namely the 156-kb PAC harbouring a 125-kb 5´ 
upstream region and a 31-kb 3´ downstream region of the AQP2 gene, was chosen for 
modification by homologous recombination in bacteria, also called ET-cloning (83).  
To introduce the Cre recombinase coding sequence in the genomic insert by homologous 
recombination in bacteria, a plasmid (pConst) containing the sequence encoding the Cre 
recombinase (84) and an ampicillin resistance cassette flanked by two FRT sites was used. The 
cloning steps are described in the Material and Methods part. Briefly, a 319-bp 5´ homology 
region of the AQP2 gene (5´ homology arm) containing the ATG at the 3´ end was amplified by 
PCR and cloned in front of the Cre recombinase coding sequence. The open reading frame of the 
Cre recombinase will therefore be inserted at the ATG of the AQP2 locus in the PAC after 
homologous recombination. A 372-bp 3´ homology region of the AQP2 gene (3´ homology arm) 
was amplified by PCR and cloned behind the ampicillin resistance cassette. The construct was 
released and electroporated into DH10B bacteria harbouring the PAC and a plasmid expressing 
the recE and recT proteins mediating the homologous recombination in bacteria (83). After 
induction of the recombination and selection with ampicillin and chloramphenicol, the positive 
clones were electroporated with a plasmid expressing the Flp recombinase to remove the 
ampicillin resistance cassette (83). Clones with the recombined PACs were identified by 
restriction site analysis with Xho1 digestion. Xho1 digestion of the wild-type PAC generates 
eight bands, one with a length of 3.8 kb. The introduction by homologous recombination in 
bacteria of the Cre recombinase coding sequence and the ampicillin resistance cassette 
introduces a new Xho1 site leading to the decrease of the 3.8-kb band to 2.5 kb, and to the 
generation of an additional band of 3.9 kb, characteristic for the modified PAC containing the 
resistance cassette. After removal of the ampicillin resistance cassette, the size of the previously 
3.9-kb band decreased to 2.8 kb, characteristic for the finaly modified PAC (Figure 7). 
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The modified genomic fragment of 156 kb containing the Cre knock-in at the ATG of the AQP2 
locus (abbreviated as AQP2Cre transgene) was released by digestion with Not I and separated 
from the PAC backbone by subsequent preparative pulsed field gel electrophoresis. The integrity 
of the homology regions and of the Cre recombinase coding sequence was checked by sequence 
analysis. The large genomic DNA fragment was purified from the gel slice by agarase digestion 
and microdialysis, and then microinjected into the pronucleus of FVB/N mouse oocytes to obtain 
AQP2Cre transgenic mice.  
 
 
 
Figure 7. Identification of the wild-type and modified AQP2Cre PACs by enzymatic digestion and 
hybridization with DNA probes. A: Schematic map of the wild-type and modified PACs showing the size of the 
DNA fragments generated after HindIII (H) or Xho1 (X) digestion and the size of the bands identified after 
hybridization with the 5´ or Cre probes. Amp: ampicillin resistance cassette. HA: homology arm. FRT: Flp 
recombinase recognition sequences orientated in the same direction resulting in removal of the flanked sequence 
upon Flp expression. B: Picture of an agarose gel showing the DNA fragments obtained after Xho1 digestion of the 
wild-type PAC (line 1), the recombined PAC containing the Amp cassette (line 2) and the recombined PAC after 
removal of the Amp cassette (line 3). C: Picture of a Southern blot membrane showing the DNA fragments obtained 
after HindIII digestion of the PACs, and identified by hybridization with the 5´ and Cre probes (lines 1: wild type 
PAC, lines 2: modified PAC with the Amp cassette, lines 3: final PAC without the Amp cassette).  
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3.1.1.2. Analysis of AQP2Cre transgenic mice  
Transgenic offsprings were identified by dot blot analysis of genomic tail DNA hybridized to a 
probe recognizing the Cre recombinase sequences (Figure 8A). Twelve independent dot blot-
positive mice were obtained from two successive oocyte injections of the AQP2Cre transgene 
and bred to C57Bl/6 mice to establish several transgenic mouse lines. Seven out of the twelve 
dot blot-positive mice showed germline transmission of the transgene to the first offspring 
generation (F1 generation). From them, three transgenic lines could be established and used for 
further analysis. For determining the transgene copy number, Southern blots were performed on 
genomic DNA from F1 mice digested with the restriction enzyme HindIII and hybridized to a 
probe recognizing the 5´ region of the AQP2 gene (5´ probe). Hybridization of the HindIII-
digested genomic DNA with the 5´ probe revealed a DNA fragment of 3.7 kb for the endogenous 
AQP2 locus (wild-type band) and of 6.4 kb for the AQP2Cre transgene integrated into the 
genome (transgenic band) (Figure 7C). The ratio of the intensities of these two bands was 
quantified by a Phospho-Imager for several blots, with the band for the endogenous AQP2 locus 
calculated as two copies (two alleles in the diploid genome). The transgene copy number for the 
three lines was determined as 1 copy, 2 copies and 4 copies, respectively (Figure 8B). The 
AQP2Cre transgenic lines were continuously backcrossed into C57Bl/6 genetic background. 
 
Figure 8. Identification and charaterization of the AQP2Cre mouse transgenic lines. A: Picture of dot blot 
membranes probed for the presence of the AQP2Cre transgene in offsprings obtained after oocyte injection. Positive 
signals for the founders of the 1-copy, 2-copy and 4-copy lines are indicated; +: positive control; -: negative control. 
B: Copy number Southern blot of HindIII-digested genomic DNA hybridized with the 5´ probe. Wt: wild-type band; 
Tg: transgenic band. C: Immunohistochemistry for Cre recombinase on kidney paraffin sections from the 1-copy, 2-
copy and 4-copy lines, respectively. 
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To investigate Cre expression at the cellular level, kidneys were taken from F1 mice from the 
three transgenic lines and analyzed for Cre recombinase protein expression using 
immunohistochemistry. An intense nuclear staining was observed in cells from CDs and distal 
tubules, identified on account of their epithelial thickness and their localization in medullary rays 
and in the cortical labyrinth adjacent to cortical radial vessels, respectively. All three lines 
exhibited a similar pattern of Cre expression in the kidney, resembling the expression of the 
endogenous AQP2 gene, and only showed transgene copy number-dependent quantitative 
differences in Cre expression levels (Figure 8C).  
 
3.1.1.3. Generation of MRAQP2Cre mutant mice 
Transgenic AQP2Cre mice from both lines showing the highest Cre expression level, namely the 
2-copy and 4-copy lines, were crossed with mice harbouring a conditional MR allele (MRflox/flox 
abbreviated as MRflox) to generate MRflox/flox//AQP2Cre (abbreviated as MRAQP2Cre) mutant mice. 
Due to limited fertility of the 4-copy line, the MRAQP2Cre mutant mice, which were analyzed were 
obtained from the 2-copy line only. Control mice used for analysis were the MRflox littermates.  
 
3.1.2. Analysis of MRAQP2Cre mutant mice 
 
3.1.2.1. MRAQP2Cre mice are able to maintain sodium balance under 
standard diet 
Colocalization of AQP2 and Cre expression in renal principal cells was confirmed by 
immunohistochemical costaining and resulted in loss of MR in AQP2-positive cells of MRAQP2Cre 
mice, but not in control mice (Figure 9). In contrast to MR inactivation in the germline (29), 
which results in inactivation of MR in all cells, inactivation of the MR gene restricted to renal 
principal cells did not impair survival, since at 4 weeks after birth a Mendelian distribution of the 
genotypes was observed. When fed with a standard diet (0.18% of sodium), control and 
MRAQP2Cre mice grew and developed normally, and exhibited similar bodyweight (controls: 21.8 
± 1.9 g, n = 15; mutants: 21.7 ± 2.0 g, n = 15, P = 0.90). No change in plasma sodium (controls: 
144.8 ± 3.4 mmol/l, n = 6; mutants: 147.7 ± 1.2 mmol/l, n = 9, P = 0.45) and potassium levels 
(controls: 5.28 ± 0.27 mmol/l, n = 6; mutants: 5.24 ± 0.06 mmol/l, n = 9, P = 0.88) as well as in 
daily urine volume (controls: 0.05 ± 0.01 ml/g bodyweight/24h, n = 15; mutants: 0.06 ± 0.01 
ml/g bodyweight/24h, n = 16, P = 0.29) and urinary sodium concentration (controls: 139 ± 6 
mmol/l, n = 15; mutants: 127 ± 4 mmol/l, n = 16, P = 0.10) was observed in MRAQP2Cre mice 
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compared to controls. Therefore, absolute sodium excretion, as calculated from urine volume and 
urinary sodium concentration, was not changed (Figure 10A), indicating that MRAQP2Cre mice 
are able to maintain sodium balance under standard conditions.  
 
 
 
Figure 9. Analysis of AQP2, Cre and MR protein expression. A: Double immunofluorescence labeling for AQP2 
(green) and Cre (red) on kidney paraffin sections. Overlap of AQP2 and Cre labeling results in a yellow signal. The 
arrow indicates an AQP2-negative intercalated cell of the CD with no Cre expression. B and C: Double 
immunohistochemical staining for AQP2 (blue) and MR (brown) on kidney paraffin sections of MRAQP2Cre (B) and 
control (C) mice. CD: collecting duct. 
 
 
3.1.2.2. MRAQP2Cre mice show increased renal loss of sodium and 
water  
Two-month old mice were challenged with a low-sodium diet (<0.01% sodium) for up to 10 
days. Both control and MRAQP2Cre mice significantly decreased the absolute sodium excretion in 
comparison to standard diet conditions (Figure 10A). This indicates that the low-sodium diet 
was effective and that the animals attempted to conserve sodium by enhancing renal sodium 
reabsorption. However, this attempt was only partially successful in the mutants, as their 
absolute sodium excretion was 70% higher after 10 days of low-sodium diet compared to 
controls. MRAQP2Cre mice showed an increase in the urine volume produced per day, but 
unchanged urinary sodium concentration compared to controls after 10 days of low-sodium diet. 
There was no significant difference in food consumption and therefore in sodium intake, as well 
as in water consumption, between both genotypes (Figures 10B-10E). Under low-sodium diet, 
also a hyperkalemia was observed in mutants (controls: 6.48 ± 0.18 mmol/l, n = 9; mutants: 7.62 
± 0.25 mmol/l, n = 7, P < 0.05). Interestingly, mutants showed a continuous loss of bodyweight 
in the homecages (Figure 10F).  
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Figure 10. Analysis of urinary sodium excretion, urine volume, urine sodium concentration, food and water 
consumption over 24 hours, and bodyweight variation after 10 days of low-sodium diet. Mice were maintained 
for the first 9 days of low-sodium diet in their homecages and placed in metabolic cages on day 10 for urine 
collection. *P<0.05, **P<0.005. n = 10-15. BW: bodyweight. 
  
 
A detailed time-course analysis of the first 5 days under low-sodium diet revealed that, from day 
2 on, MRAQP2Cre mice show increased renal sodium excretion compared to controls, whereas 
within the first 24 hours no genotype effect was detected (Figure 11A). Whereas the urinary 
sodium concentration was unchanged in mutant mice compared to control mice over the whole 
salt-restriction period, MRAQP2Cre mice showed increased urine volume production resulting in 
increased renal sodium excretion (Figure 11B). Both genotypes showed no significant difference 
in food and water consumption over time (data not shown). 
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Figure 11. Time-course analysis of urinary sodium excretion (A) and urine volume (B) over 24 hours during 5 
days of low-sodium diet. Mice were placed in metabolic cages for 5 days for urine collection. *P<0.05, **P<0.005. 
n = 5 per group. BW: bodyweight. 
 
 
 
Histological examination of the kidneys of two-month old mice did not reveal any tubular or 
interstitial abnormalities, except for focal enlargement of the juxtaglomerular apparatus, the site 
of renin production, in MRAQP2Cre mice, indicating an activation of the renin-angiotensin-
aldosterone system (RAAS) (Figure 12A). Indeed, determination of plasma aldosterone levels 
revealed a dramatic increase in MRAQP2Cre mice. After 3 days of low-sodium diet, as expected, 
plasma aldosterone increased in controls compared to standard diet conditions. However, an 
increase was also detected in mutants to the same extent. Under both diets, mutants exhibit 10-
fold elevated plasma aldosterone levels compared to controls. After 10 days of low-sodium diet, 
plasma aldosterone increased further in both genotypes and mutants still exhibited 6-fold 
increased levels (Figure 12B).  
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Figure 12. Analysis of the renin-angiotensin-aldosterone system (RAAS) activation. A: Hematoxylin-eosin 
histological staining of kidney paraffin sections from control and MRAQP2Cre mice under standard diet. Arrows 
indicate focal enlargement of juxtaglomerular renin-producing granular cells. B: Plasma aldosterone levels 
measured in control and MRAQP2Cre mice under standard diet (n = 15) or after 3 days (n = 15) or 10 days (n = 5) of 
low-sodium diet. **P<0.005. 
 
3.1.2.3. MRAQP2Cre mice show preserved ENaC activity  
To examine whether ENaC-mediated renal sodium reabsorption was affected in MRAQP2Cre mice, 
the effect of amiloride, a specific blocker of ENaC, on the excreted part of the sodium filtered by 
the kidney (fractional excretion of sodium, abbreviated as FE(Na+)) was determined. Since after 
10 days of low-sodium diet MRAQP2Cre and control mice show a similar glomerular filtration rate 
(GFR) determined by measuring the creatinine clearance within 24 hours (controls: 6.63 ± 0.32 
µl/g bodyweight/min, n = 15; mutants: 6.17 ± 0.49 µl/g bodyweight/min, n = 15, P = 0.45), the 
direct comparison of FE(Na+) between controls and mutants is possible. In the absence of 
amiloride, FE(Na+) tended to be higher in MRAQP2Cre mice than in controls, suggesting salt 
wasting. However, the difference between both genotypes did not reach significance within the 
2-hour sampling period (controls: 0.17 ± 0.04%, n = 5; mutants: 0.24 ± 0.04%, n = 6, P = 0.20), 
probably due to incomplete collection of the urine from the bladder and high variation and error 
in small urine volumes collected during a short period of time. As expected, amiloride strongly 
increased FE(Na+) in controls. Surprisingly, amiloride had a comparable effect on FE(Na+) in 
MRAQP2Cre mice, indicating preserved renal ENaC activity in the mutants (Figure 13).  
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Figure 13. Analysis of renal ENaC activity. Determination of the effect of amiloride on the fractional excretion of 
sodium (FE(Na+)) in untreated (white bars) and amiloride-treated (black bars) control and MRAQP2Cre mice after 10 
days of low-sodium diet. The FE(Na+) was calculated as ([urine sodium]/[plasma sodium])*([plasma 
creatinine]/[urine creatinine]). **P<0.005 (t-test treated versus untreated). Untreated groups: n = 5-6; amiloride-
treated groups: n = 11-13. 
 
 
3.1.2.4. MRAQP2Cre mice show loss of MR and apical αENaC in CD 
and late CNT  
Since MRAQP2Cre mice showed preserved amiloride-sensitive renal sodium reabsorption, renal 
ENaC expression was assessed by immunohistochemistry in control and mutant mice after 10 
days of low-sodium diet. As reported previously (85), the apical ENaC subunit α (αENaC) 
staining detected in controls was weaker in CD (Figure 14A) compared to CNT (Figure 14C). 
In MRAQP2Cre mice, both MR and αENaC stainings were absent in all principal cells of cortical 
CD (Figure 14B) and in most principal cells of the CNT (Figure 14D), demonstrating efficient 
targeting of MR in these tubular segments and the crucial role of MR expression for αENaC 
trafficking to the cell surface. However, some principal cells of the CNT retain MR and also 
apical αENaC expression (Figure 14D, arrows). Closer inspection and co-immunostainings 
with antibodies against calbindin D28k and the thiazide-sensitive sodium-chloride cotransporter 
(TSC), established markers for the distal tubule subsegments (86), revealed strong expression of 
Cre in the CD and decreasing levels along the CNT towards the early CNT. In this subsegment, 
Cre expression was undetectable (Figures 15A and 15B). Detailed analysis of MR and αENaC 
expression revealed that the cells retaining MR and apical αENaC expression are situated in the 
early CNT, adjacent to the transition from DCT to CNT, and in the late DCT (Figure 15C). 
Thus, MRAQP2Cre mice exhibit targeting of the MR gene and loss of apical αENaC expression in 
CD and late CNT. The early CNT, however, is not targeted due to undetectable Cre expression. 
A gross survey revealed that about 30% of the CNT principal cells were not targeted. 
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Figure 14. Analysis of MR and αENaC protein expression. Collecting duct (CD) and connecting tubule (CNT) 
from control (A and C) and MRAQP2Cre (B and D) mice kept for 10 days under low-sodium diet. Double 
immunofluorescence on the same cryosection with antibodies against αENaC and MR, respectively. A and C: In 
control, apical αENaC is well detectable in MR-expressing cells of CD (A) and CNT (C), with stronger expression 
in CNT cells. B: In MRAQP2Cre, apical αENaC and MR immunostainings are absent from principal cells in CD, 
which express high levels of Cre as shown by immunofluorescence on a consecutive cryosection (low magnification 
insert). D: In CNT of MRAQP2Cre, apical αENaC and MR are absent from most of the CNT cells. Only few CNT cells 
(arrows) retain MR and apical αENaC staining. 
 
 
 
 
 
Figure 15. Detailed analysis of Cre expression along the distal nephron. Immunofluorescent labeling for Cre, 
calbindin D28k (CB), thiazide-sensitive sodium-chloride cotransporter (TSC), αENaC and MR on cryosections 
from a MRAQP2Cre mouse kept for 10 days under low-sodium diet. CD: collecting duct; CNT: connecting tubule; D: 
distal convoluted tubule; V: cortical radial vessel; *: early CNT; arrows: detectable low Cre staining.  
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3.1.2.5. MRAQP2Cre mice show unchanged TSC activity but increased 
colonic ENaC activity  
To determine whether elevated plasma aldosterone observed in MRAQP2Cre mice could act on 
other sodium-reabsorbing MR-expressing epithelia than the early CNT, the activity of TSC in 
DCT and ENaC in colon were assessed. The activity of TSC, expressed in DCT and described to 
be activated by aldosterone (87), was determined by measuring FE(Na+) under low-sodium diet 
before and after treament with thiazide, a specific TSC blocker. In both genotypes, no change in 
the thiazide-sensitive portion of the FE(Na+) was observed  (Figure 16A). In contrast, the colon 
was responding to the elevated plasma aldosterone levels. MRAQP2Cre mice exhibit an 1.7-fold 
increased amiloride-sensitive transepithelial voltage compared to control mice under standard 
diet, and a 1.5-fold increase when challenged under low-sodium diet (Figure 16B).  
 
 
Figure 16. Analysis of TSC activity in the renal DCT and ENaC activity in the colon. A: Determination of the 
effect of thiazide on the fractional excretion of sodium (FE(Na+)) in untreated and thiazide-treated control and 
MRAQP2Cre mice after 10 days of low-sodium diet. TSC: thiazide-sensitive sodium-chloride cotransporter. **P<0.005 
(t-test treated versus untreated). Untreated groups: n = 5-6; thiazide-treated groups: n = 6-8. B: Difference in rectal 
transepithelial voltage measured before and after amiloride-treatment (ΔV) in controls and MRAQP2Cre mice under 
standard diet or after 10 days of low-sodium diet. ENaC: amiloride-sensitive epithelial sodium channel. *P<0.05, 
**P<0.005 (t-test MRAQP2Cre versus control). n = 6 per genotype. 
 
3.2. Generation of an inducible renal principal cell-specific 
gene inactivation system  
 
Principal cell MR-deficient (MRAQP2Cre) mice were generated in order to determine the role of 
renal principal cell MR in the control of sodium reabsorption. However, before generating the 
MRAQP2Cre mice, the inactivation of MR in principal cells was expected to be the cause of 
lethality in MR knockout mice. Indeed, germline inactivation of the mouse MR gene results in 
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early postnatal lethality due to renal loss of sodium and water caused by strongly impaired ENaC 
activity in renal principal cells and colon. Since AQP2 is already expressed prenataly (88), it was 
expected that the early targeting of MR in all principal cells would mimic the early postnatal 
phenotype of the MR knockout mice. To be able to induce the MR mutation only in adulthood, 
an inducible renal principal cell-specific gene inactivation system was developped in parallel 
using the same genomic DNA fragment as for the construction of the constitutive transgene. The 
inducible recombination system that was used is based on a fusion protein consisting of the Cre 
recombinase and a mutated ligand-binding domain of the human estrogen receptor (89). The Cre 
fusion protein (CreERT2) is not activated by endogenous estrogen but by the synthetic ligand 
tamoxifen. If expressed in the absence of tamoxifen, the inducible CreERT2 remains in the 
cytoplasm. In the presence of tamoxifen, CreERT2 is translocated to the nucleus where it can 
exert its enzymatic activity and therefore leads to recombination of floxed alleles (79, 81, 90). 
 
3.2.1. Generation of AQP2CreERT2 mice  
 
Transgenic mice expressing the CreERT2 fusion protein under the control of the AQP2 gene 
(AQP2CreERT2 mice) were generated as described for the constitutive AQP2Cre mice. Briefly, 
the PAC used for the generation of the constitutive AQP2Cre transgene, which was isolated from 
a mouse PAC library and contains a 156-kb genomic DNA fragment, was modified by 
homologous recombination in bacteria in order to introduce the CreERT2 fusion protein coding 
sequence at the ATG of the AQP2 locus. The cloning of the construct was performed using the 
same strategy as for the constitutive approach, except that a plasmid (pIndu), containing the 
CreERT2 fusion protein coding sequence and an ampicillin resistance cassette flanked by two 
FRT sites, was used instead of the pConst plasmid. After removal of the ampicillin resistance 
cassette and release from the PAC backbone, the modified fragment (AQP2CreERT2 transgene) 
was purified and microinjected into FVB/N oocytes. Transgenic offsprings were identified by 
dot blot on genomic DNA using a DNA probe detecting the Cre recombinase sequences as 
described for the constitutive AQP2Cre transgenic mice (Figure 17A). Seven dot blot-positive 
mice were obtained and bred to C57Bl/6 mice to establish different transgenic lines. All dot blot-
positive mice showed germline transgene transmission to the F1 generation. From them, three 
transgenic lines could be established and used for further analysis. For determination of the 
transgene copy number, Southern blot was performed on HindIII-digested genomic DNA. 
Hybridization with a probe recognizing the 5´ region of the AQP2 gene (5´ probe) revealed a 
3.7-kb DNA fragment for the endogenous AQP2 gene (wild-type band), and a 2.3-kb DNA 
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fragment for the AQP2CreERT2 transgene integrated into the genome (transgenic band) (Figure 
17B). The copy number of the three transgenic lines was determined as 1 copy, 4 copies and 9 
copies, respectively.  
 
Figure 17. Identification and characterization of the AQP2CreERT2 mouse transgenic lines. A: Picture of the 
membranes of two dot blots probed for the presence of the AQP2CreERT2 transgene in offsprings obtained after 
oocyte injection. 1-copy, 4-copy and 9-copy: founders of the 1-copy line, 4-copy line and 9-copy line, respectively. 
B: Copy number Southern blot of HindIII-digested genomic DNA hybridized with the 5´probe detecting the AQP2 
promoter sequence present in the transgene and in the endogenous locus, as illustrated in Figure 7. Wt: wild-type 
band; Tg: transgenic band. C: Immunohistochemical staining for Cre recombinase on paraffin sections from oil- or 
tamoxifen-injected AQP2CreERT2 mice. D: Kidney cryosections from oil- or tamoxifen-injected 
AQP2CreERT2//Rosa26 mice stained for X-gal (blue staining) and counter-stained with eosin. A kidney cryosection 
from a tamoxifen-injected Rosa26 mouse stained for X-gal and counter-stained with eosin was used as control 
without transgene. E: Kidney cryosection from a tamoxifen-injected AQP2CreERT2//Rosa26 mouse of the 1-copy 
line stained for X-gal (blue staining) and AQP2 expression (brown staining). The picture in the little pannel shows 
CDs from the cortical region at a higher magnification with AQP2-positive cells without recombination. F: Time-
course of tamoxifen injection and analysis of recombination. 
 
 
3.2.2. Analysis of AQP2CreERT2 mice 
In order to assess the functionality of the CreERT2 fusion protein, the nuclear translocation of the 
fusion protein upon tamoxifen treatment was investigated by immunohistochemistry on 
cryosections from mice carrying the AQP2CreERT2 transgene, injected with vehicle (oil) or 
tamoxifen, and killed 1 hour after injection. In vehicle-injected mice, the CreERT2 fusion protein 
  Results  
 34 
was located in the cytoplasm and also in the nucleus of CD principal cells of the cortex and 
medulla. In tamoxifen-injected mice, a strong nuclear Cre staining was observed in principal 
cells, whereas no fusion protein was detected in the cytoplasm, reflecting the nuclear 
translocation upon tamoxifen induction (Figure 17C). In addition, the 4-copy line showed 
stronger expression of the CreERT2 fusion protein than the 2-copy line, which displayed a 
stronger CreERT2 expression than the 1-copy line, indicating a copy number-dependent CreERT2 
protein expression (data not shown). 
To determine the ability of the Cre recombinase to selectively recombine conditional alleles in 
renal principal cells in vivo, the AQP2CreERT2 mice were bred to a Cre reporter line (Rosa26 
mice) (91). The Cre reporter line carries at the ROSA26 locus a knock-in of a loxP-flanked 
STOP cassette in front of a LacZ coding sequence encoding the β-galactosidase. The β-
galactosidase cannot be expressed from the Cre reporter allele unless the STOP cassette is 
excised after Cre-mediated recombination. Offsprings carrying both the AQP2CreERT2 transgene 
and the Cre reporter allele (abbreviated as AQP2CreERT2//Rosa26 mice), confirmed by PCR 
analysis on genomic DNA, received one i.p. injection of 1 mg tamoxifen per day for 5 
consecutive days. Ten days after the last injection, mice were sacrificed and kidneys collected. 
Cryosections were X-gal stained to reveal expression of the β-galactosidase reporter gene 
indicating successful Cre-mediated recombination (Figure 17D). As a control for recombination-
independent β-galactosidase activity and for background of the X-gal staining procedure, Rosa26 
mice carrying no AQP2CreERT2 transgene were injected with tamoxifen. No blue signal was 
observed, indicating that the X-gal staining procedure does not produce any background and that 
the STOP cassette is tight (Figure 17D). Vehicle (oil) injections were performed on 
AQP2CreERT2//Rosa26 mice to serve as control for non-induced Cre-mediated recombination. 
These vehicle-treated mice showed blue staining in some tubular cells of the medullary rays of 
the outer and inner medulla, and very intense staining in tubular cells of the papilla, indicating 
constitutive recombination in these cells. Inducibility of the Cre-mediated recombination was 
assessed in AQP2CreERT2//Rosa26 mice after tamoxifen injection. All three transgenic lines 
showed tamoxifen-induced β-galactosidase activity particularly in cortical CDs and much more 
intense β-galactosidase staining in the regions where the leakiness of the fusion protein was 
observed (Figure 17D).  
To determine whether Cre activity was specific for principal cells, colocalization of AQP2 
protein expression and Cre-mediated recombination was assessed by immunohistochemistry for 
AQP2 on X-gal stained cryosections from AQP2CreERT2//Rosa26 mice after tamoxifen 
induction. Since the 9-copy line could not be maintained because of low breeding efficiency, 
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further analysis was perfomed on the 1-copy and 4-copy lines only. In both lines, AQP2 protein 
expression and the recombination event were colocalized in every principal cells of the medulla. 
However, some AQP2-positive cells of the cortex did not show any blue signal (Figure 17E).  
Since the constitutive MRAQP2Cre mutant mice grew and developed normally and only upon low-
sodium diet developed a salt-wasting phenotype, AQP2CreERT2 mice were not used to generate 
inducible renal principal cell MR-deficient mice. 
 
3.3. Identification of aldosterone-regulated genes possibly 
involved in the control of ENaC-mediated renal sodium 
reabsorption  
 
As shown above, MRAQP2Cre mice show loss of apical αENaC expression in MR-deficient 
principal cells of CD and late CNT and impaired renal sodium reabsorption. In order to identify 
aldosterone-regulated genes involved in the control of ENaC-mediated sodium reabsorption in 
principal cells, gene expression profiling using microarrays was performed on a mouse kidney 
cortical CD principal cell line (mpkCCDc14) in the presence or absence of aldosterone. In vivo 
validation of the aldosterone-regulated genes identified by gene expression profiling in the cell 
line was done on microdissected CDs of control mice kept under standard diet or challenged with 
low-sodium diet. The contribution of MR to the aldosterone response in vivo was assessed by 
comparing gene expression in microdissected CDs from principal cell MR-deficient (MRAQP2Cre) 
mice and control mice. 
 
3.3.1. Sodium transport in mpkCCDc14 cells is mediated by 
ENaC and regulated by aldosterone via GR 
The mpkCCDc14 cell line established by Bens et al. has retained the sodium transport capacity as 
well as its regulation by aldosterone (92). In addition to the fact that the isolation of principal 
cells from native tissue is technically difficult, the use of the cell line allows easy hormone 
depletion, thereby increasing the fold change in gene expression between the untreated (baseline) 
and the aldosterone-treated state. In addition, the mpkCCDc14 cell line allows easy measurement 
of the transepithelial sodium transport. Thus, this cell line provides an easy and powerful system 
to identify aldosterone-regulated genes involved in CD principal cell sodium reabsorption. 
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For determination of ion transport, mpkCCDc14 cells were grown to confluence on permeable 
Transwell filters, which allow the formation of a tight epithelium. The short-circuit current (Isc), 
which is a measure of the sodium flow across the epithelium from the apical to the basolateral 
compartment, was calculated from the measured transepithelial electrical resistance (RT) and 
voltage (UT) according to Ohm´s law (Isc = UT / RT).  
The effect of aldosterone on sodium transport was assessed by measuring Isc in the presence or 
absence of aldosterone on cells incubated in hormone-free and steroid-free medium for 48 hours. 
Aldosterone was used at 10-6 M, a dose which was shown to lead to a strong elevation in Isc in a 
time-dependent manner with a maximum increase observed after 4 hours of treatment (92). The 
rise in Isc was due to a decrease in RT and a increase in UT, suggesting an effect of aldosterone on 
the ion transport. In the presence of amiloride, no induction by aldosterone could be observed, 
showing that it is the electrogenic amiloride-sensitive ENaC-mediated sodium transport that is 
stimulated by aldosterone (Figure 18). Moreover, the Isc levels measured after amiloride 
treatment were below the baseline levels measured in untreated cells, indicating the existence of 
a constitutive aldosterone-independent ENaC-mediated sodium transport.  
In order to determine whether aldosterone regulation of sodium reabsorption in mpkCCDc14 is 
mediated by MR or the glucocorticoid receptor (GR), the effect of aldosterone was measured 
with and without a 10-fold excess of the specific MR antagonist spironolactone, and with or 
without a 10-fold excess of the specific GR antagonist RU486. Spironolactone had no effect on 
Isc in the presence of aldosterone, whereas RU486 prevented a rise in Isc during aldosterone 
treatment, indicating that the aldosterone response is mediated by GR in mpkCCDc14 cells 
(Figure 18). 
 
Figure 18. Sodium transport in mpkCCDc14 cells is mediated by ENaC and regulated by aldosterone via GR. 
Transepithelial sodium transport was assessed by measuring the short-circuit current Isc in the presence of vehicle or 
aldosterone (10-6 M), and with or without the ENaC blocker amiloride (5.10-6 M), the GR antagonist RU486 (10.10-6 
M), or the MR antagonist spironolactone (10.10-6 M). 
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3.3.2. Gene expression profiling of mpkCCDc14 cells 
In order to identify aldosterone-regulated genes involved in the control of renal principal cell 
sodium reabsorption, microarrays analysis of gene expression was performed on mpkCCDc14 
cells in the presence or absence of aldosterone. Cells were grown on Transwell filters and 
incubated in hormone-free and steroid-free medium before and during treatment with vehicle 
(untreated control) or aldosterone for 1 hour, 2 hours or 4 hours. Determination of Isc was 
performed at each time point to confirm the hormonal response. RNA samples prepared from 
lysed cells from two Transwell filters were pooled and used to generate probes for hybridization 
of the Affymetrix mouse expression MOE 430 2.0 A and B arrays. For each time point, three 
sets of untreated and aldosterone-treated RNA samples were independently prepared (Figure 
19A). Microarray data were controlled for quality, scaled, and normalized to correct for technical 
variations between arrays using the GC-RMA software of the Bio-Conductor Project. For each 
microarray, the GC-RMA software generates a signal value, which assigns a relative measure of 
abundance of the transcript. Additionally, a detection p-value is calculated, determining whether 
a transcript is reliably detected (present) or not detected (absent). For each time point (1 hour, 2 
hours and 4 hours), a comparison analysis between arrays corresponding to untreated or 
aldosterone-treated cells was carried out to detect and quantify changes in gene expression. The 
software generates a quantitative estimate of the change in gene expression between the 
aldosterone-treated and untreated samples called fold-change (FC) and a corresponding p-value. 
A gene was considered as significantly changed when the FC of treated versus untreated cells 
was lower or higher than 1.4 and the p-value lower than 0.001 for at least one out of the three 
time points. The cut-off value for FC was chosen in order to obtain a reasonable number of 
genes. For the p-value, the cut-off value was chosen according to standard procedure. However, 
biologically relevant gene expression changes may or may not be effectively captured with a 
given statistical method, and the list of genes found to be significantly changed by one method 
may contain false positives and false negatives. In order to confirm the results obtained with the 
GC-RMA software and to narrow down the list of candidate genes by removing potential false 
positives and false negatives, microarray data were additionally analyzed with the SAS 
Microarray Solution software, and the lists of genes obtained with both methods were compared 
(Figure 19B). For the analysis with the SAS Microarray Solution software, a FC lower or higher 
than 1.4 and a p-value lower than 0.002 were used as criteria for significantly changed genes. 
The cut-off value for the p-value was chosen in order to obtain a number of genes significantly 
changed in the range of that obtained with the GC-RMA software. 
  Results  
 38 
 
Figure 19. Gene expression profiling of mpkCCDc14 cells. A: Experimental design: mpkCCDc14 cells were 
grown on 12-well Transwell filter plates and treated with vehicle or aldosterone (10-6 M) for 1 hour, 2 hours or 4 
hours. The aldosterone response was assessed by measuring the short-circuit current Isc. For each treatment 
condition and each time-point, 3 replicates were independently prepared, mRNA was isolated from lyzed cells from 
two pooled Transwell filters and used for hybridization on Affymetrix MOE 430 2.0 A and B microarrays. B: 
Analysis of microarray data: microarray data were normalized and analyzed using the GC-RMA and SAS 
Microarray Solution softwares, and results obtained with both methods were compared to generate the final list of 
aldosterone-regulated genes. 
 
Independent of the method used, no genes were identified as downregulated with the chosen cut-
off values for FC and the p-value. To compare the lists of genes obtained with both methods, the 
significantly upregulated genes were ranked by decreasing FC for the three time points. There 
was a very good overlap between the two lists for the most highly induced genes. For the 1-hour 
aldosterone treatment, the same genes were found upregulated by both methods, except for one 
gene, which was not detected with the SAS Microarray Solution software. For the 2-hour time 
point, there was a 60% overlap between both lists, with almost 100% overlap for the 12 most 
strongly induced genes. At 4 hours, there was a 100% overlap for the 18 most strongly induced 
genes and 75% overlap for the 35 most induced genes with almost the same ranking (with 
decreasing FC). Mutual exclusion of the induced genes predicted with each software was 
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performed and only the genes, which were detected as aldosterone-upregulated by both methods, 
were further analyzed. The mutual exclusion allowed the identification of 10 induced genes at 1-
hour aldosterone treatment, 30 induced genes at 2 hours and 47 upregulated genes at 4 hours 
(Table 1). The serum- and glucocorticoid-regulated kinase 1 (SGK1) was identified as the most 
highly induced gene at each time point with both methods (GC-RMA estimated fold-changes: 
FC1h = 17.5, FC2h = 26, FC4h = 46). The genes encoding the glucocorticoid-induced leucin zipper 
protein (GILZ, also called DSIP1), the serine/threonine-protein kinase 3 (PIM3) and the dual 
specificity phosphatase 6 (Dusp6) were found among the most induced transcripts at each time 
point with both methods.  
 
Table 1. Lists of aldosterone-induced genes identified by gene expression profiling on mpkCCDc14 cells after 
1-hour, 2-hour or 4-hour aldosterone treatment. The fold changes in gene expression between aldosterone-
treated and untreated cells, determined with the GC-RMA and the SAS Microarray Solution softwares, are indicated 
next to the gene name or Affymetrix ID for unknown genes. For each time-point of aldosterone treatment, genes are 
ranked by decreasing fold change. Genes chosen for further analysis in vivo are indicated with coloured rectangles. 
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The identified potential target genes that might be involved in the control of ENaC-mediated 
sodium reabsorption were checked for available functional information about the encoded 
proteins, using the Gene Ontology (GO) annotation of the mouse genome, and grouped by their 
possible mechanistic interaction with ENaC activity. Among the highly aldosterone-induced 
genes, genes encoding transcription factors (e.g. GILZ) were identified, as well as genes 
encoding proteins involved in post-translation modifications like kinases (e.g. SGK1, PIM3), 
ubiquitination proteins (e.g. the ubiquitin-specific protease 2 USP2), or proteins involved in 
protein transport (e.g. the GTPase RAB17). Figure 20A shows these potentially interesting 
genes as well as the pathways and protein functions used for classifying the aldosterone-
regulated genes obtained in the microarray experiment. 
The action of aldosterone on sodium transport can be operationally divided into two major 
phases: an early phase of sodium transport increase, and a late phase starting around 3 hours after 
hormone addition, during which a further increase in transport activity is observed. To 
distinguish the early aldosterone-regulated genes from the late aldosterone-regulated genes and 
to identify genes involved in the control of ENaC during both phases, a hierarchical cluster 
analysis of RNA expression data was used to group genes with similar expression profiles during 
the aldosterone treatment (1 hour, 2 hours and 4 hours) (Figures 20B and 20C). SGK1, GILZ 
and PIM3 showed a clear increase in mRNA expression already after 1 hour of aldosterone 
treatment and remained highly induced during the 4 hours of treatment. USP2, RAB17, and 
interestingly also αENaC, were found to be upregulated after 2 hours and 4 hours of treatment. 
Since aldosterone induction suggests a direct regulation under the transcriptional control of the 
hormone receptor, a search for glucocorticoid response elements (GREs) in the promoter region  
(10 kb upstream of the ATG) (13) was performed with the Possum program using the consensus 
sequence CGZACAANNTGTYCTK (93) provided as a weighted matrix in the TRANSFAC 
program (94). Apparent GRE sequences, matching the consensus sequence with a threshold 
value of at least 85%, were found in the promoter regions of PIM3 (87%), GILZ (86%) and 
SGK1 (85%). 
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Figure 20. Identification of aldosterone-induced genes potentially involved in regulation of ENaC activity. A: 
Schematic representation of the different pathways potentially involved in the regulation of ENaC upon aldosterone 
stimulation, leading to increased sodium reabsorption in renal principal cells. The genes identified as aldosterone-
induced by gene expression profiling in mpkCCDc14 cells and potentially involved in the ENaC regulatory pathways 
are indicated in red. B: Hierarchical cluster analysis of transcripts significantly changed after 1-hour, 2-hour and 4-
hour aldosterone treatment. Changes in expression (log2 ratio) are scaled by differences in colour for each transcript. 
The blue and red scales indicate decreases or increases in expression. C: Expression profiles of the serum- and 
glucocorticoid-regulated kinase 1 (SGK1), the glucocorticoid-induced leucin zipper protein (GILZ), the 
serine/threonine-protein kinase 3 (PIM3), the epithelial sodium channel subunit α (αENaC), the ubiquitin-specific 
protease 2 (USP2) and the GTPase Rab17 (RAB17) during aldosterone treatment. The graphs represent the log2 
expression values at each time-point of aldosterone treatment. Open and filled circles represent estimated log2 
expression values from untreated and aldosterone-treated cells, respectively. Broken and solid lines connect average 
of log2 expression values in untreated and aldosterone-treated cells, respectively.  
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3.3.3. Validation of aldosterone-induced genes in 
microdissected CDs 
To validate the microarray experiment in vivo, the expression of selected genes (αENaC, SGK1, 
GILZ, PIM3, RAB17, 14-3-3β and USP2) was checked by quantitative real-time PCR (RT-PCR) 
in microdissected collecting ducts (CDs) of MR-expressing control mice fed with standard diet 
or low-sodium diet for 10 days that lead to a 7-fold elevation of plasma aldosterone levels in 
control mice. CDs were identified by the presence of branching connections, which define the 
end of the CNT and the start of the CD. The mRNA was isolated and RT-PCR carried out using 
HPRT as endogenous housekeeping gene for normalization. The analysis was focused on 
previously identified aldosterone-induced genes as positive controls, like αENaC, SGK1 and 
GILZ, and on candidates derived from the microarray experiment on mpkCCDc14 cells, whose 
protein function could obviously be involved in ENaC regulation by aldosterone, like Rab17, a 
protein involved in protein transport, the kinase Pim3, which contains a GRE in its promoter 
region, and the ubiquitin-specific protease Usp2, which could activate ENaC by deubiquitination 
of the channel. The protein 14-3-3β was also analyzed since it was described to participate in the 
regulation of ENaC activity (95). 
As shown in Figure 21A, SGK1 and USP2 gene expression underwent upregulation in CDs 
from control mice under low-sodium diet compared to standard diet, confirming the aldosterone 
response observed in the cell line. 14-3-3β was also induced under low-sodium diet. αENaC, 
GILZ and PIM3 showed a tendency to be upregulated under low-sodium diet, but the increase 
did not reach statistical significance. RAB17, which was found strongly induced in the cell line 
with a FC similar to the one for αENaC, did not show any induction under low-sodium diet in 
CDs of control mice. 
 
3.3.4. Effect of MR deficiency on the aldosterone response in 
vivo 
In order to investigate in vivo the role of MR in mediating the induction by aldosterone of genes 
potentially involved in the control of ENaC-mediated renal sodium reabsorption, quantitative 
RT-PCR was performed on mRNA isolated from microdissected CDs of principal cell MR-
deficient (MRAQP2Cre) and control mice challenged with low-sodium diet (10 days). As expected, 
despite strong plasma aldosterone elevation in MRAQP2Cre mice (10-fold compared to control 
mice), expression levels of SGK1 and PIM3 were significantly reduced in the mutants, showing 
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that the aldosterone regulation of these genes, in response to the low-sodium diet, is mediated by 
MR in CDs (Figure 21B). Gene expression levels of αENaC showed only a tendency to be 
reduced in the mutants, suggesting that MR might also mediate the upregulation of αENaC by 
aldosterone in CDs. In contrast, no change in gene expression was observed for GILZ, 14-3-3β 
and USP2, suggesting that the induction of GILZ, 14-3-3β and USP2 expression by aldosterone 
is not dependent on MR. 
 
Figure 21. Gene expression analysis by real-time PCR on microdissected CDs from control (MRflox) mice or 
principal cell MR-deficient (MRAQP2Cre) mice. Relative expression of genes (versus HPRT) in microdissected 
collecting ducts (CDs) of control mice under standard or low-sodium diet (10 days) (A) or in microdissected CDs of 
control and MRAQP2Cre mice under low-sodium diet (10 days) (B). n = 5 per group. *P<0.05, **P<0.005 (t-test low-
sodium diet versus standard diet, or MRAQP2Cre mice versus control mice).  
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4. DISCUSSION 
 
4.1. Selective inactivation of MR in mouse renal principal 
cells 
 
4.1.1. MRAQP2Cre mice are viable and show MR deficiency in all 
principal cells of the CD and late CNT 
The present study reports the generation of mice with specific inactivation of the MR gene in 
renal principal cells (MRAQP2Cre mice). MRAQP2Cre mice were generated using the Cre-loxP 
recombination system by crossing mice harboring a conditional MR allele with transgenic mice 
expressing the Cre recombinase under the control of the regulatory elements of the mouse AQP2 
gene, which is expressed in principal cells of the collecting duct (CD) and connecting tubule 
(CNT) (40). The AQP2 promoter was already used for Cre recombinase expression to target 
renal principal cells. However, both a 14-kb human and a 9.5-kb mouse AQP2 promoter 
fragments gave variegated patterns of transgene activity (96, 97). Therefore, a PAC-derived large 
genomic DNA fragment containing a 125-kb 5´ upstream region, thought to carry all elements 
required for high-fidelity tissue-specific and temporal regulation of the AQP2 gene activity (76), 
was used to generate the transgene. Furthermore, the use of a PAC-derived transgene should 
allow a copy number-dependent expression of the transgene (98). 
Whereas the germline inactivation (knockout) of the mouse MR gene results in early postnatal 
lethality due to a massive renal loss of sodium and water (29), the renal principal cell-specific 
inactivation of MR did not impair survival. Therefore, MRAQP2Cre mice allowed the investigation 
of the role of principal cell MR in regulation of epithelial sodium channel (ENaC)-mediated 
sodium reabsorption. In contrast to the MR knockout mice, not all tight epithelia that are 
involved in sodium reabsorption were targeted in MRAQP2Cre mice. The use of the regulatory 
elements of the mouse AQP2 gene restricted the MR deficiency to the principal cells in kidney. 
The analysis of Cre, MR and αENaC expression by immunofluorescence revealed that the Cre 
expression of the PAC-derived transgene resembles the AQP2 expression pattern, with strong 
expression in CD and decreasing levels along the CNT towards the early CNT (40). The 
AQP2Cre transgene used in the present study therefore allowed the targeting of all ENaC-
expressing principal cells of the CD and late CNT. The targeted cells were MR-negative and 
showed no apical αENaC expression. However, MR and apical αENaC expression was still 
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observed in the early CNT and late DCT, which were not targeted due to absence of Cre 
expression. These data demonstrate for the first time in vivo by genetic means that αENaC 
trafficking to the cell surface is strictly dependent on MR function.  
 
4.1.2. The late CNT is an important site of MR-regulated 
ENaC-mediated sodium reabsorption 
MR knockout mice die in the second week after birth, due to severe renal loss of sodium and 
water, and show decreased ENaC-mediated sodium reabsorption in kidney and colon (29). In 
contrast, MRAQP2Cre mice are viable, grow normally and show unaltered absolute sodium 
excretion when fed with a standard diet. When challenged with a low-sodium diet, MRAQP2Cre 
mice suffer from a continuous sodium wasting, as indicated by elevated absolute sodium 
excretion, and from a continuous water loss, as shown by the continuous increased urine volume 
associated with a loss of bodyweight.  
To counterbalance the loss of MR in the principal cells of the CD and late CNT, the renin-
angiotensin-aldosterone system (RAAS) was activated in MRAQP2Cre mice under standard as well 
as under low-sodium diet, as detected by the strongly elevated plasma aldosterone levels. Under 
standard diet, the aldosterone increase was apparently sufficient to achieve a complete 
compensation. However, when sodium supply was limited, the even stronger activation of the 
RAAS could no longer fully compensate the MR deficiency in MRAQP2Cre mice. It was previously 
reported that mice with αENaC deficiency in the CD (αENaCHoxb7Cre mice) showed no change in 
renal sodium and water excretion (99). Compared to controls, the αENaC-deficient mice showed 
normal plasma aldosterone levels on both standard and low-sodium diet indicating that the 
αENaC loss in CD did not result in any impairement of sodium reabsorption. These results led to 
the conclusion that the increased renal sodium excretion and the observed elevation of plasma 
aldosterone levels measured in MRAQP2Cre mice result primarily from the loss of MR in the late 
CNT. The importance of the CNT in ENaC-mediated sodium reabsorption is highlighted by a 
recent patch-clamp study, which showed that ENaC-mediated sodium transport is several times 
higher in the CNT than in the CD in aldosterone-treated rats (100). This is consistent with a 
previous study on isolated perfused nephron segments, which showed that the rate of sodium 
reabsorption is much higher in the CNT than in the CD (101).  
Since in MR knockout mice most of the amiloride effect on ENaC activity is abolished (29), 
ENaC activity in MRAQP2Cre mice was expected to be clearly reduced. Therefore, an increase in 
the fractional excretion of sodium (FE(Na+)) and a reduced amiloride-sensitive portion of the 
  Discussion  
 46 
FE(Na+) were expected in the mutants. However, MRAQP2Cre mice showed, within an acute 2-
hour sampling procedure, only a tendency to higher FE(Na+) as compared to controls. Morover, 
amiloride treatment led to a similar strong increase in FE(Na+) in both genotypes. Most likely, 
the early CNT and the late distal convoluted tubule (DCT) that were not targeted and 
consequently still express apical ENaC are responsible for the preserved amiloride action. Since 
in the untargeted colon of MRAQP2Cre mice ENaC activity is increased due to elevated plasma 
aldosterone levels, increased sodium transport in the early CNT and late DCT is also expected, 
which represents an intrinsic renal compensatory mechanism.  
The unchanged acute FE(Na+) and preserved ENaC activity in MRAQP2Cre mice are not easy to 
reconcile with the salt-wasting syndrome leading to a continuous loss of bodyweight as it was 
observed at low sodium supply. A possible explanation is that the assessment of acute FE(Na+) is 
not sensitive enough as it only allows the detection of a 3-fold increase as measured in 
heterozygous MR knockout mice (29). Therefore, minor changes that still could account for the 
70% increase observed in absolute sodium excretion over 24 hours, as well as minor changes in 
the amiloride-sensitive part of the FE(Na+), might have escaped from this type of analysis. To 
detect minimal changes in renal ENaC activity, more sophisticated quantitative analysis using 
patch-clamp of single cells or microperfusion of nephron segments are required. However, the 
visually indistinguishable boundary of the early and late CNT that can vary from animal to 
animal hampers these types of analysis.  
 
4.1.3. Other possible compensatory actions triggered by 
increased plasma aldosterone levels  
Besides activating MR in untargeted principal cells of the early CNT and late DCT, the elevated 
plasma aldosterone levels may also activate sodium reabsorption mediated by the thiazide-
sensitive sodium-chloride cotransporter (TSC) in the DCT, as well as the ENaC-mediated 
sodium reabsorption in the colon. For the colon, measurement of the amiloride-sensitive rectal 
transepithelial voltage showed that MRAQP2Cre mice exhibit a 30% increase in colonic ENaC 
activity. However, the colon is known to reabsorb only about 5% of the total amount of 
reabsorbed sodium. Moreover, sodium transport in the colon is almost absent after weaning 
compared to the early life time (102). Thus, it is unlikely that colonic ENaC activity plays a 
major role in the compensation of MR loss in CD and late CNT. Since the renal principal cells 
were selectively targeted, the analysis of MRAQP2Cre mice was focused on ENaC-mediated renal 
sodium reabsorption. However, several studies had shown that the thiazide-sensitive sodium-
chloride transport (103) and TSC abundance in DCT (87) are both induced by aldosterone via 
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MR (104). In order to determine whether the 10-fold increase in plasma aldosterone levels 
observed in MRAQP2Cre mice would also act on TSC, thus leading to increased sodium 
reabsorption, the activity of the sodium-chloride cotransporter was assessed by measuring renal 
FE(Na+) before and after application of thiazide. No gain of TSC function was observed in 
mutants compared to control mice. These results suggest that the DCT does not participate to the 
compensation for the loss of MR in CD and late CNT.  
 
4.2. Generation of an inducible renal principal cell-specific 
gene inactivation system 
 
Since germline inactivation of the mouse MR gene (MR knockout mice) results in early 
postnatal lethality due to massive loss of sodium and water caused by impaired ENaC activity in 
renal principal cells and colon (29), it was expected that the prenatal constitutive inactivation of 
MR in renal principal cells (MRAQP2Cre mice) would result in a similarly strong phenotype that 
may even lead to lethality. To be able to induce the MR gene inactivation in adulthood, an 
inducible renal principal cell-specific gene inactivation system was generated in parallel using 
the Cre-loxP recombination system in combination with the CreERT2 fusion protein. The fusion 
protein consists of the Cre recombinase and a mutated ligand-binding domain of the human 
estrogen receptor, which allows the nuclear translocation of the fusion protein upon tamoxifen 
treatment, resulting in tamoxifen-dependent gene inactivation (89). Transgenic mice expressing 
the CreERT2 under the control of the regulatory elements of the mouse AQP2 gene were 
generated and three transgenic lines with different copy numbers of the transgene (1, 4 and 9 
copies) were established and analyzed. Induction of recombination was achieved by i.p. injection 
of 1 mg tamoxifen once a day for 5 days (105). The expression of the AQP2CreERT2 transgene 
resembles that of the endogenous AQP2 gene and of the constitutive AQP2Cre transgene. In the 
different transgenic lines, the expression of the Cre recombinase shows only copy number-
dependent quantitative differences but similar expression pattern. Nuclear translocation of the 
fusion protein upon tamoxifen treatment was observed 2 hours after tamoxifen injection in every 
line, indicating that the CreERT2 fusion protein is functionning.  
To determine the recombination efficiency, each line was crossed with a Cre reporter mouse line 
(Rosa26 mice) containing a loxP-flanked STOP cassette in front of a lacZ expression cassette 
within the ubiquitously expressed ROSA26 locus (91). Cre-mediated recombination in 
tamoxifen-injected AQP2CreERT2//Rosa26 mice deleted the STOP cassette and thereby resulted 
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in β-galactosidase expression that was revealed by X-gal staining on cryosections. In all three 
transgenic lines, tamoxifen-independent recombination was observed in the papilla region and in 
some tubular cells of the medullary rays in the outer and inner medulla, indicating that the 
control of Cre activity exerted by the ERT2 domain was not tight. Since every recombination 
event results in an irreversible deletion of the STOP cassette, cells containing a recombined lacZ 
allele will accumulate overtime. Therefore, even low leakiness of the CreERT2 fusion protein 
activity in the absence of tamoxifen can result in a high number of recombined cells. Moreover, 
the possible presence of tamoxifen-like molecules in the renal papilla, which could bind to the 
ERT2 domain, could lead to induction of the recombination in this region of the kidney. 
Nevertheless, analysis of  β-galactosidase staining in tamoxifen-injected AQP2CreERT2//Rosa26 
mice revealed tamoxifen-induced recombination in most of the renal principal cells for all three 
transgenic lines. The pattern and degree of recombination were comparable to that observed in 
the constitutive AQP2Cre line. The two inducible lines with the highest transgene copy number 
(4 and 9 copies) showed a higher efficiency of the tamoxifen-induced β-galactosidase activity.  
To determine whether Cre activity was restricted to principal cells, colocalization of AQP2 
protein expression and Cre-mediated recombination was assessed by immunohistochemistry for 
AQP2 on X-gal stained cryosections from AQP2CreERT2//Rosa26 mice after tamoxifen 
induction. In the medulla, AQP2 expression and the recombination event were colocalized. 
However, few AQP2-positive cells of the cortex did not show any blue signal, suggesting a lack 
of recombination in these cells. Since in the case of the inducible AQP2CreERT2 transgene, the 
Cre activity is only transiently activated during the period of tamoxifen application, the pattern 
of recombination reflects expression of the fusion protein at the time period of tamoxifen 
treatment, which might not be enough to induce recombination in every cell. Injection of a 
higher dose of tamoxifen or the same dose but twice a day could extend the number of 
recombined cells.  
Since the constitutive MRAQP2Cre mutant mice did not show any lethality allowing a detailed 
functional analysis of the phenotype, inducible renal principal cell-specific MR gene inactivation 
(MRAQP2CreERT2 mice) were not generated. However, these MRAQP2CreERT2 mice could improve the 
description of the recombination efficiency by analyzing the loss of MR upon tamoxifen 
treatment.  
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4.3. Identification of MR-regulated genes potentially 
involved in the control of principal cell ENaC-mediated 
sodium reabsorption  
 
4.3.1. Gene expression profiling of mpkCCDc14 cells reveals 
aldosterone-induced genes potentially involved in ENaC 
regulation  
To identify aldosterone-regulated genes involved in the control of ENaC-mediated sodium 
reabsorption in renal principal cells, microarray analysis was performed in a mouse kidney 
cortical collecting duct principal cell line (mpkCCDc14) in the absence or presence of 
aldosterone. The effect of aldosterone on sodium transport was assessed by measuring the short-
circuit current. The results of the amiloride treatment showed that sodium reabsorption in 
mpkCCDc14 cells is mediated by ENaC. Kidney collecting ducts, like other targets for 
corticosteroid hormones, possess two types of corticosteroid receptors, which bind to the same 
palindromic DNA sequence (13): a receptor with a high affinity for aldosterone (MR) and a 
receptor with a low affinity for aldosterone (GR) (106),(107). The high concentration of 
aldosterone (10-6 M), necessary to stimulate maximal sodium reabsorption in mpkCCDc14 cells, 
suggests that occupancy of GR by aldosterone is required. The question was therefore whether 
the increased sodium reabsorption elicited by aldosterone was mediated via the occupancy of 
MR and/or GR. The fact that the MR antagonist spironolactone had no effect on the short-circuit 
current in the presence of aldosterone, whereas the GR antagonist RU486 prevented completely 
the rise in the current induced by aldosterone, indicates that the ENaC-mediated sodium 
reabsorption in the mpkCCDc14 cells is regulated by GR under high aldosterone concentrations, 
confirming previous binding assays (92). However, it was shown before that high doses of 
glucocorticoids in adult salt-rescued MR knockout mice normalized the urinary sodium excretion 
and could increase ENaC activity, showing that the role of MR in activation of ENaC activity 
can be taken over by GR (108). Therefore, the mpkCCDc14 cell line should still allow the 
identification of the aldosterone-regulated genes that are important for ENaC regulation in vivo.  
To identify aldosterone-regulated genes, RNA from mpkCCDc14 cells was subjected to 
microarray analysis after treatment with aldosterone or vehicle. The action of aldosterone can be 
operationally divided into two phases: an early phase of sodium transport increase mediated by 
aldosterone-induced regulatory proteins acting on the preexisting transport machinery (66), and a 
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late phase during which a further increase in transport activity correlates with an increase in 
channels, pumps, and other elements of the transport machinery (109, 110). Therefore, cells were 
treated with aldosterone for 1 hour, 2 hours or 4 hours to distinguish between aldosterone-
regulated genes contributing to the early phase of the hormone response and those contributing 
to the late phase. As data analysis performed with the GC-RMA (111) and the SAS Microarray 
Solution softwares gave consistent results for each time point, mutual exclusion of the 
upregulated genes predicted with both softwares was performed and only genes found in 
common were further analyzed. This resulted in the identification of 53 genes upregulated by 
aldosterone. Downregulated genes were not found. One of the genes induced by aldosterone was 
the ENaC subunit α (αENaC), but its time course of induction (starting after 2 hours) indicates 
that the transcriptional activation of this gene takes place during the late phase of aldosterone 
response. Candidate genes for the early activation of ENaC activity should be already regulated 
by aldosterone during its early phase of action (before 2 hours). Among the early and most 
induced genes, SGK1, GILZ, DUSP6 and PIM3 were identified. SGK1 showed the highest fold 
change at each time point, consistent with previous gene expression profiling studies (61, 112). 
In addition, several other genes not previously described as induced by aldosterone were also 
identified, extending the list of aldosterone-regulated transcripts.  
The aldosterone-regulated genes obtained from the microarray analysis were grouped by 
function of the encoded proteins, in order to identify those genes that are potentially involved in 
the regulation of ENaC activity. ENaC activity has been shown to be regulated at different 
levels: channel protein synthesis, distribution of the channels between intracellular pools and 
transport to the apical membrane, channel open probability and stability (113-115). Control of 
channel surface density and channel degradation involves covalent modifications of the ENaC 
proteins themselves and/or interaction with other regulatory proteins. Sgk1, one of the best 
characterized aldosterone-induced proteins involved in the regulation of ENaC activity, was 
shown to increase apical membrane ENaC by inhibiting the ubiquitin ligase Nedd4-2 through 
recruitment of 14-3-3 proteins, which reduces the ability of Nedd4-2 to ubiquitinate ENaC (68), 
(116, 117). Gilz has recently been shown to contribute to the early aldosterone stimulation of 
ENaC-mediated sodium current through inhibition of ENaC ubiquitination by Nedd4-2 via the 
ERK cascade (112). In addition to αENaC, Sgk1 and Gilz, the present study revealed that the 
ubiquitin-specific protease Usp2 is also induced by aldosterone. Ubiquitination is reversed by a 
number of proteases that specifically recognize ubiquitinated proteins and remove the ubiquitin 
tag (118). By deubiquitination of ENaC, Usp2 could participate to the activation of the channel. 
Similarly, the GTPase Rab17 was also found as aldosterone-induced. Rab17, expressed only in 
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kidney, liver and intestine, has been shown to regulate membrane trafficking through apical 
recycling of endosomes in polarized epithelial cells (119, 120) and could therefore be involved in 
ENaC regulation by participating to the trafficking of the channel to the apical membrane. 
Finally, it has also been shown that ENaC activity is regulated by phosphorylation via 
serine/threonine kinases (121). In this context, the early (1 hour) and marked induction by 
aldosterone of the expression of the PIM3 gene and the presence of a GRE in its promoter region 
makes PIM3 a potential newly described MR target gene involved in the mediation of the 
aldosterone response in renal principal cells.  
 
4.3.2. The regulation of SGK1 and PIM3 by aldosterone is 
mediated by MR in microdissected CDs  
Because of their high induction upon aldosterone treatment in mpkCCDc14 cells and of their 
encoded protein function, PIM3, RAB17 and USP2 were chosen for further mRNA expression 
analysis in vivo. αENaC, SGK1 and GILZ were also included in the analysis as genes already 
described to regulate ENaC activity. To verify that these genes are also regulated by aldosterone 
in vivo, mRNA expression was analyzed by quantitative RT-PCR on microdissected collecting 
ducts (CDs) from control mice kept under standard diet or after 10 days of low-sodium diet, 
which lead to 7-fold increase in plasma aldosterone levels. The mRNA expression of 14-3-3β 
was also analyzed, despite the fact that this transcript was not detected in the cell line. SGK1, 14-
3-3β and USP2 mRNA expression levels were significantly elevated in CDs after 10 days of 
low-sodium diet. αENaC, GILZ and PIM3 expression levels only showed a tendency to be 
upregulated after salt restriction, but the increase did not reach statistical significance. RAB17 
mRNA expression levels did not show any change between both diet conditions. The results of 
the RT-PCR confirmed the microarray data for SGK1 and USP2 and suggest that these two 
genes, as well as 14-3-3β, are potential targets for aldosterone regulation of ENaC activity in CD 
principal cells. For αENaC, GILZ, PIM3 and RAB17, the discrepancy between the results from 
the microarrays and the RT-PCR on microdissected CDs, in terms of FC and statistical 
significance of FC, is probably due to the low number of observations and the lack of sensitivity 
of the system used. Indeed, in contrast to the cell line, which possesses only one type of cells 
(principal cells), microdissected CDs contain also intercalated cells, which do not express ENaC 
and therefore miss the aldosterone regulation, thus diluting the aldosterone response of the 
principal cells. Moreover, the microdissected CDs from control mice under standard diet are not 
hormone-depleted. Changes in gene expression occuring after switch to low-sodium diet might 
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therefore escape from this type of analysis. The use of adrenalectomized mice infused with 
vehicle or aldosterone could increase the sensitivity of the system and allow a more complete 
identification of aldosterone-regulated transcripts.  
To establish a correlation between the modulation of the mRNA levels of the genes induced by 
aldosterone via MR and potentially involved in ENaC regulation, and the physiological effects of 
the loss of MR in CD principal cells in MRAQP2Cre mice, quantitative RT-PCR was performed on 
microdissected CDs from control and MRAQP2Cre mice after 10 days of low-sodium diet. Despite 
strongly elevated plasma aldosterone levels in MRAQP2Cre mice, the expression levels of SGK1 
and PIM3 were clearly reduced in mutant mice after 10 days of low-sodium diet. These results 
show for the first time in vivo, using a non-pharmacological approach, that MR is regulating the 
transcription of SGK1 and PIM3 in CDs. This suggests that SGK1 and PIM3 are involved in the 
impaired ENaC-mediated sodium reabsorption leading to salt wasting in MRAQP2Cre mice. 
However, the action of aldosterone to control renal sodium reabsorption is most likely 
pleiotropic and might therefore not be only dependent on SGK1 and PIM3. This was already 
concluded from the analysis of SGK1 knockout mice that showed, despite elevated plasma 
aldosterone levels, only a mild salt-wasting phenotype (70). The expression levels of αENaC 
showed a tendency to be reduced in MRAQP2Cre mice, but not significantly probably due to the 
lack of sensitivity of the system used, as discussed before. The regulation of αENaC by 
aldosterone might therefore be also mediated by MR. The expression levels of GILZ, 14-3-3β 
and USP2 were unchanged between control and mutant mice, suggesting that the regulation of 
these three genes by aldosterone is not dependent on MR.  
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 5. CONCLUSION AND OUTLOOK 
It is still widely accepted that “the collecting duct is the main nephron segment where sodium 
reabsorption is adjusted to maintain excretion at a level appropriate for dietary intake” (122). 
This statement reflects the emphasis that has been placed on the role of the collecting duct (CD) 
in the final control of sodium reabsorption. The recent generation of the CD αENaC-deficient 
mice has demonstrated that ENaC expression in the CD is not required for maintaining sodium 
balance (99). The present study reports that mice deficient for MR in principal cells of the whole 
CD and late connecting tubule (CNT) (MRAQP2Cre mice) grow and develop normally under 
standard diet. The switch to low-sodium diet results in continuous loss of bodyweight due to 
increased renal loss of sodium and water. The mutant mice show dramatically elevated plasma 
aldosterone levels on both standard and low-sodium diet. Under low-sodium diet, no apical 
αENaC expression was detectable in the late CNT and CD. These data show for the first time 
using a genetic approach the crucial role of MR for ENaC trafficking in vivo. In adition, the 
presented data show that the targeted inactivation of MR in CD and late CNT can be 
compensated on a standard diet by activation of the renin-angiotensin-aldosterone system, but 
that this compensation fails when sodium supply is limited. The preserved renal ENaC activity 
observed in the mutant mice indicates that the deficient ENaC-mediated sodium reabsorption in 
the late CNT and CD can be compensated to a large extent by the late distal convoluted tubule 
(DCT) and early CNT, demonstrating the pivotal role of these two distal nephron segments. 
Whether there is remaining ENaC-mediated sodium reabsorption in MR-deficient CD cells of 
MRAQP2Cre mice and to which extent ENaC-mediated sodium reabsorption is upregulated in MR-
expressing cells of the late DCT and early CNT of MRAQP2Cre mice remains to be determined. 
This would require a more sophisticated quantitative assessment of the renal ENaC activity using 
patch-clamp analysis of single cells and/or microperfusion of distinct tubular segments, and 
analysis of sodium reabsorption using micropuncture.  
The present study also reports the establishment of a tamoxifen-inducible renal principal cell-
specific gene inactivation system in mice using the Cre-loxP recombination system. Cre reporter 
mice revealed induction of gene inactivation but also some leakiness of the fusion protein. The 
generation of inducible renal principal cell-specific MR-deficient mice will allow, by analyzing 
the loss of MR, a better assessment of the recombination efficiency. 
Finally, the present work describes additional aldosterone-regulated genes and shows that SGK1 
and USP2 are induced upon low-sodium diet in microdissected CDs. In addition, the present 
study shows for the first time in vivo by genetic means that the regulation of SGK1 and PIM3 by 
aldosterone in CDs is mediated by MR.  
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6. MATERIALS AND METHODS 
 
6.1. Materials 
6.1.2. Chemicals and radioactivity 
The chemicals used were provided by Fluka (Germany), Roth (Germany), Sigma (Germany), 
and Merck (Germany).  
DNA probe radiolabeling was performed with α-32P-dCTP (3000 Ci/mmol, 10 mCi/ml) provided 
by Amersham (Germany). 
 
6.1.3. Enzymes 
Restriction enzymes were provided by Roche Molecular Biochemicals (Germany), New England 
Biolabs (Germany), or Promega (Germany). Taq Polymerase, Klenow-fragment, Shrimps 
alkaline phosphatase, T4 DNA ligase, and T4 polynucleotide kinase were provided by Roche 
Molecular Biochemicals (Germany), Pfu DNA polymerase by Promega (Germany), RNase A by 
Qiagen (Germany), and proteinase K by Roth (Germany). All enzymatic reactions were 
processed in the reaction buffer provided by the manufacturer. 
 
6.1.4. Bacterial strains 
DH10B:  
The PAC library RPCI21 (RPZ, Germany) has been cloned in the DH10B bacterial strain. 
Therefore all steps for the modification of the PAC were done in DH10B bacteria. 
 
NM554:  
This bacterial strain was provided by Stratagene (Germany) and used for the cloning of plasmids. 
After preparation for transformation competency, bacteria were transformed with the plasmid by 
the heat-shock method. 
 
6.1.5. Plasmids 
pConst and pIndu: 
Both plasmids, used as expression- and cloning-vectors for the generation of the constitutive and 
inducible transgenes respectively, were generated and provided by Dr. Erich Greiner (DKFZ, 
Heidelberg, Germany). These plasmids contain the human Cre recombinase (84) under the 
control of the CMV promoter. They also carry an ampicillin resistance cassette flanked by two 
FRT sites, which can therefore be removed by Flp recombination. The pIndu carries a fusion of 
the Cre recombinase with a mutated ligand-binding domain of the human estrogen receptor 
alpha, whose activity is induced by tamoxifen (89). 
 
pBADR6KαβγtetR (ET-plasmid) and p705-Flp: 
Both plasmids, used to modify the PAC by homologous recombination in bacteria (ET-cloning), 
were provided by Dr. A. Francis Stewart (EMBL, Heidelberg, Germany). 
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6.1.6. DNA microarrays 
The GeneChip Mouse Expression Arrays MOE 430 2.0 A and B were purchased from 
Affymetrix (USA). These two oligonucleotide arrays contain over 45000 probe sets representing 
more than 39000 transcripts and variants, including over 34000 well-characterized mouse genes. 
 
6.1.7. Buffers and solutions 
6.1.7.1. Isolation and storage of DNA 
Plasmid DNA:  TE buffer, pH 8.0: 10 mM Tris-HCl, pH 8.0 
1 mM EDTA, pH 8.0 
 
Genomic DNA:  TE buffer, pH 7.4:  10 mM Tris-HCl, pH 7.4 
1 mM EDTA, pH 8.0 
 
Minipreps:  STET buffer:  50 mM Tris-HCl, pH 8.0 
      50 mM EDTA 
      5% Triton X-100 
      8% saccharose   
 
PAC DNA Mini and Midipreps: P1 buffer (Qiagen): 100 µg/ml RNase A 
50 mM Tris-HCl, pH 8.0 
10 mM EDTA, pH 8.0 
 
P2 buffer (Qiagen): 200 mM NaOH 
1% SDS 
 
P3 buffer (Qiagen): 3 M potassium acetate, pH 5.5 
 
DNA preparation from mouse tail: NID buffer: 50 mM KCl  
10 mM Tris-HCl, pH 8.3  
2 mM MgCl2  
0.1 mg/ml gelatine  
0.45% NP40   
0.45% Tween 20   
 
Tail buffer: 50 mM Tris-HCl  
100 mM EDTA  
100 mM NaCl  
20% SDS  
 
6.1.7.2. DNA electrophoresis 
50X Tris-acetate buffer (TAE) : 2M Tris 
250 mM sodium acetate 
50 mM EDTA, pH 8.0 
pH 7.8 (adjusted with HCl) 
Diluted 1X TAE was used as running buffer for gel electrophoresis.  
 
6X loading buffer:  0.25% bromophenol blue 
0.25% xylene cyanol FF 
15% Ficoll 400 
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The marker Smart Ladder (Stratagene) was used as DNA size marker by loading 10 µl in one 
well. 
 
6.1.7.3. DNA probe radiolabeling 
5X OLB-C:  100 µl Solution A 
250 µl 2 M HEPES, pH 6.6 
150 µl Random Hexamers pd(N)6 (50 O.D.260 dissolved in 550 µl TE) 
 
Solution A:  1 ml Solution B 
18 µl β-mercaptoethanol 
5 µl each 100 mM dATP, dGTP, dTTP 
  
Solution B:  1.25 M Tris-HCl, pH 8.0 
125 mM MgCl2 
 
6.1.7.4. Southern blot 
Denaturation buffer:  0.5 M NaOH 
    1.5 M NaCl 
 
Neutralization buffer:  0.5 M Tris-HCl, pH 7.0 
    1.5 M NaCl 
 
Blot buffer (20X SCC): 0.3 M sodium acetate  
    3 M NaCl 
    pH 7.0 (adjusted with NaOH)   
 
6.1.7.5. Dot blot 
Denaturation buffer:  0.5 M NaOH 
    1.5 M NaCl 
 
Neutralization buffer:  0.5 M Tris-HCl, pH 8.0 
    1.5 M NaCl 
 
Equilibration buffer:  0.2 M Tris-HCl, pH 8.0 
    2X SCC 
 
6.1.7.6. DNA hybridization 
Hybridization buffer:  0.5 M NaHPO4, pH 7.2 
(Church buffer)  1 mM EDTA, pH 8.0 
    7% SDS 
 
Washing buffer I:  40 mM NaHPO4, pH 7.2 
    1 mM EDTA, pH 8.0 
    5% SDS 
 
Washing buffer II:  0.5 M NaHPO4, pH 7.2 
    1 mM EDTA, pH 8.0 
    1% SDS  
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6.1.7.7. Bacteria culture media 
LB medium: 10 g Bacto-trypton (Difco) 
  5 g yeast extract (Difco) 
  5 g NaCl 
  for 1 l final volume, pH 7.2 (adjusted with NaOH), autoclaved 
 
LB Agar: 1X LB medium 
  1.5% (mass/volume) bacto-agar (Difco) 
 
6.1.7.8. mpkCCDc14 cell culture (92) 
Standard culture medium (150 ml) : 75 ml HAMF´12 (Gibco) 
   75 ml DMEM (Gibco) 
     5 µg/ml insulin (Sigma) 
     5.10-8 M dexamethasone (Sigma)  
     60 nM selenium (Sigma) 
     5 µg/ml transferrin (Sigma) 
     5.10-8 M triodothyronine (Sigma) 
     10 ng/ml EGF (Sigma) 
     20 mM HEPES (Gibco) 
     2 mM glutamine (Gibco) 
     2% FCS (Seromad) 
     3.36 ml D-glucose (Sigma) 
 
Hormone-free medium:  
This medium has the same composition as the standard culture medium, but without insulin, 
dexamethasone, triodothyronine and EGF, and contains 2% CTS (Seromad) instead of FCS. 
 
Hormone-free and serum-free medium:  
This medium has the same composition as the hormone-free medium, but without CTS. 
 
Cells were treated with aldosterone, amiloride, RU486 or spironolactone provided by Sigma 
(Germany).  
 
6.1.7.9. DNA microarrays 
5X first strand cDNA buffer:  50 mM Tris-HCl, pH 8.3 
75 mM KCl 
3 mM MgCl2 
 
5X second strand cDNA buffer: 25 mM Tris-HCl, pH 7.5 
100 mM KCl 
5 mM MgCl2 
10 mM (NH4)SO4 
0.15 mM b-NAD+  
 
5X fragmentation buffer: 4 ml 1 M Tris-acetate, pH 8.1 
0.64 g MgOAc 
0.98 g KOAc 
DEPC-water to 20 ml, filtered through 0.28-µm vacuum filter unit 
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6.1.7.10. DNA microinjection into mouse oocytes 
Agarase buffer: 10 mM Tris-HCl, pH 6.5 
   1 mM EDTA, pH 8.0 
   100 mM NaCl 
   30 µM spermine 
   70 µM spermidine 
 
Microinjection buffer:  10 mM Tris-HCl, pH 7.5 
0.1 mM EDTA, pH 8.0 
100 mM NaCl 
 
The composition of the M2- and M16-media is decribed in (123). 
Mice were superovulated by injection of PMS-gonadotropin and chorion-gonadotropin provided 
by Sigma. 
 
6.1.7.11. Rosa26 mouse reporter assays 
Fixation solution: 0.1 M PBS, pH 7.3 
5 mM EGTA 
2 mM MgCl2 
0.2% glutaraldehyde 
 
Washing solution:  0.1 M PBS, pH 7.3 
5 mM EGTA 
2 mM MgCl2 
0.01% sodium-deoxycholat 
 0.02% NP40 
 
Staining solution: 0.1 M PBS, pH 7.3 
5 mM EGTA 
2 mM MgCl2 
0.01% sodium-deoxycholat 
0.02% NP40 
10 mM K3[Fe(CN)6]e III (329.25 g/mol) 
10 mM K4[Fe(CN)6]f II (422.4 g/mol) 
0.5 mg/ml X-Gal in DMF 
 
6.1.8. Genomic PAC library  
The genomic PAC library RPCI21 (RZPD, Germany) constructed by K. Osoegawa (Rosewell 
Park Cancer Institute) was screened for PACs containing the AQP2 gene. The library represents 
12.6 times the genome of a female 129/SvevTACfBr mouse. The genomic fragments of 147 kb 
are cloned in the P1-derived artificial chromosome (PAC) pPAC4. DNA clones are fixed on 
high-density filters, which were hybridized with a DNA probe recognizing the AQP2 gene. The 
positive clones were provided as transformed bacteria in agar with 0.025 mg/ml kanamycin. 
 
6.1.9. mpkCCDc14 cell line 
The mpkCCDc14 cell line was provided by Prof. Alain Vandewalle (INSERM Unité 478, Paris, 
France). This cell line is a clonal immortalized cell line derived from mouse cortical collecting 
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duct (92). In the present study, cells of passage number 5-20 were used (passage nuber 1 
corresponds to the first passage after recieving the cell line from Paris). 
 
6.1.10. Mouse strains 
C57Bl/6:  
This strain was used for the backcrossing of transgenic mice. Per definition, transgenic mice 
have 100% of C57Bl/6 genetic background after 10 generations of backcrossing with C57Bl/6 
mice. 
 
FVB/N:  
This strain is an inbred mouse strain, which was used for transgenesis (oocytes microinjection).   
  
6.1.11. Probes and primers 
6.1.11.1. Primers for PCR 
All primers used for PCR were ordered by MWG-Biotech AG (Munich, Germany). 
 
Primers for analytic genotyping PCRs: 
 
MR floxed allele: 
MR flox-7 Forward 5´-CTGGAGATCTGAACTCCAGGCT-3´ 
MR flox-8 Reverse 5´-CCTAGAGTTCCTGAGCTGCTGA-3´ 
MR flox-10 Reverse 5´-TAGAAACACTTCGTAAAGTAGAGCT-3´ 
 
AQP2Cre and AQP2Cre-ERT2 transgenes: 
AQP2-12 Forward 5´-AAGTGCCCACAGTCTAGCCTCT-3´ 
AQP2-13 Reverse 5´-GGAGAACGCTATGGACCGGAGT-3´ 
CAMK-2 Reverse 5´-CCTGTTGTTCAGCTTGCACCAG-3´ 
 
 
ROSA26 reporter: 
ROSA-1 Forward 5´-TCTGCTGCCTCCTGGCTTCTGA-3´ 
ROSA-2 Reverse 5´-CCAGATGACTACCTATCCTCCCA-3´ 
ROSA-3 Reverse 5´-AAGCGCATGCTCCAGACTGCCT-3´ 
 
Primers for preparative PCR for amplification of homology arms: 
 
5´homology arm: 
AQP2-5´hom-1 Forward 5´-ATCGTTTAAACAGAGACGTCAATCCTTATCTG-3´ 
AQP2-5´hom-2 Reverse 5´-CATGCTGCTCGGCCTTCTGAG-3´ 
 
3´homology arm: 
AQP2-3´hom-1 Forward 5´-GCTCTAGATGGGAACTCCGGTCCATAGCG-3´ 
AQP2-3´hom-2 Reverse 5´GATGCTAGCGTTTAAACTCGGGCTACTCACAGCATT-3´ 
 
 
6.1.11.2. Probes and primers for RT-PCR 
Probes and primers for TaqMan reactions were ordered by Applied Biosystems (Germany) and 
provided within an Assay kit for each gene tested. 
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Gene name Applied Biosystems Assay ID 
αENaC Mm00803386_m1 
GILZ Mm00726417_s1 
HPRT Mm00446968_m1 
PIM3 Mm00446876_m1 
RAB17 Mm00436205_m1 
SGK1 Mm00441380_m1 
USP2 Mm00497460_g1 
14-3-3β  Mm00457545_m1 
 
 
6.2. Methods 
6.2.1. Standard technics of molecular biology 
6.2.1.1. DNA isolation 
 
6.2.1.1.1. Miniprep of plasmid DNA from bacteria 
This method was adapted from (124) and is suitable for preparation of small amount of DNA for 
screening of bacterial clones. 1 ml of an overnight bacterial culture was centrifuged (14000 rpm) 
and resuspended in 400 µl of STET buffer. After addition of 32 µl of a lysozyme solution (10 
mg/ml), the preparation was heated for 2 min at 95°C, then cooled down for 30 min at 4°C and 
centrifugated (14000 rpm, 15 min, 4°C). The pellet was removed and 800 µl of 100% ethanol 
were added to the supernatant. After 10 min at RT, the preparation was centrifuged (10 min, 
4°C), the supernatant removed and the pellet washed once with 80% ethanol. After 
centrifugation (5 min, 4°C), the pellet was air-dried and then resuspended in 100 µl of TE. 
 
6.2.1.1.2. Midiprep of plasmid DNA from bacteria 
Preparation of big quantities of plasmid DNA was performed using the QiaFilter Plasmid 
Midi/Maxi Kit (Qiagen, Germany) according to the manufacturer´s instructions. In the present 
study, only Midipreps were performed from 25 ml of overnight bacterial cultures using the tip-50 
Qiafilter cartridges (Qiagen). The concentration of the DNA preparation (diluted in TE pH 8.0) 
was determined by UV-photometry by measuring the extinction at 260 nm and 280 nm. 
 
6.2.1.1.3. Miniprep of PAC DNA  
The size of the PAC (140-150 kb circular supercoiled DNA) and its low quantity in a bacterial 
culture (1-2 copies/bacteria) require a different preparation method than the one used for plasmid 
DNA. The bacterial colonies identified as PAC-positive were inoculated in 2-ml LB medium 
containing Kanamycin (0.025 mg/ml). After centrifugation (4000 rpm, 10 min, 4°C), the cultures 
were resuspended and lyzed by alkaline lysis (125) using P1-, P2-, and P3-buffers from Qiagen. 
The neutralized lysate was then centrifuged (14000 rpm, 10 min, 4°C). The DNA contained in 
the supernatant was precipitated by addition of 600 µl of isopropanol and centrifugated (14000 
rpm, 10 min, 4°C). The pellet was washed with 70% ethanol, centrifuged for 5 min at 4°C, dried 
and resuspended in 40 µl of TE pH 8.0. The concentration and quality of the DNA was checked 
by gel electrophoresis. 
 
6.2.1.1.4. Midiprep of PAC DNA 
Midiprep of PAC DNA was performed using Q20-columns and reagents from Qiagen. The 
bacterial colonies identified as PAC-positive were inoculated in 50-ml LB medium containing 
kanamycin (0.025 mg/ml). After centrifugation, the cultures were resuspended and lyzed by 
alkaline lysis. The neutralized lysate was then centrifuged (4000 rpm, 20 min, 4°C). After 
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filtering on cheesecloth filter, the DNA contained in the supernatant was precipitated by addition 
of 10 ml of isopropanol and centrifugation (4000 rpm, 20 min, 4°C). The pellet was resuspended 
in 1 ml of QBT buffer. After equilibration of the Q20-column with 1 ml of QBT buffer, the 
resuspended pellet was applied on the column for 5 min. After 3 washing steps with 2 ml of QC 
buffer and centrifugation at 4°C, the DNA was eluted 2 times with 800 µl of hot (70°C) QF 
buffer, precipitated with 560 µl isopropanol and centrifuged for 15 min at 4°C. The pellet was 
then washed with cold 70% ethanol, centrifuged (14000 rpm, 10 min, 4°C), dried and 
resuspended in 25 µl TE pH 8.0. The concentration and quality of the DNA were checked by gel 
electrophoresis. For Midiprep of PAC DNA for microinjection, the resuspension was done in 10 
µl of TE only and exonuclease activity was inactivated by incubation at RT for 10 min and then 
at 65°C for 15 min. 
 
6.2.1.1.5. DNA preparation from mouse tail  
For DNA preparation for PCR, a 2-mm long piece of mouse tail was incubated at 56°C overnight 
in 0.2 ml of NID buffer with 2 µl of proteinase K (10 mg/ml). After heat inactivation of the 
proteinase K for 10 min at 96°C, 2 µl of the DNA preparation were used for genotyping PCR. 
For DNA preparation for dot blot, the piece of tail was incubated at 56°C overnight in 0.72 ml of 
tail buffer with 40 µl of proteinase K (10 mg/ml).  
 
6.2.1.1.6. Preparative gel electrophoresis of linear DNA fragment  
DNA fragments from preparative restriction digestion or PCR reactions were separated from 
other DNA fragments or oligodeoxynucleotides by agarose gel electrophoresis as described 
previously. After staining with ethidium bromide, DNA fragments were visualized under long-
wavelength UV light (the short-wavelength UV light damages the DNA). The piece of gel 
containing the DNA fragment with the desired size was cut out from the gel and placed in 2 ml 
of reaction buffer. The DNA was prepared from the gel piece according to the QIAquick Gel 
Extraction Kit protocol (Qiagen, Germany) and resuspended in 40 µl of water. The concentration 
and quality of the DNA preparation were checked by agarose gel electrophoresis. 
 
6.2.1.1.7. Preparative PFGE of linear PAC DNA fragments  
Pulsed field gel electrophoresis (PFGE) is a technique used to separate especially long fragments 
of DNA by length. It operates by alternating electric fields to run DNA through a flat gel matrix 
of agarose. In the present study, 100 µg of digested PAC DNA were resolved on a 1% Sea-Plug 
low-melting point agarose (Sigma) gel in 0.5X TAE running buffer using the Electrophoresis 
Cell device connected to the CHEF-DR III system (Biorad) according to the manufacturer´s 
instructions. The following parameters were used: initial tswitch = 0.2 s, final tswitch = 12 s, included 
angle α = 106°, E = 6 V/cm, I ≅ 140 mA, total time T = 14 h. For the detection of the DNA 
fragments, only the gel parts containing the ladder (cut out from the rest of the gel) were stained 
with ethidium bromide. The gel piece containing the linear digested PAC was cut out and the 
agarose was digested with β-agarase at 40°C for 2 h. Non-digested agarose was removed by 
centrifugation and the DNA was purified using ultracentrifugation cartridges. For microinjection 
of the PAC DNA into mouse oocytes, the DNA was further purified by dialysis with 
microinjection buffer for 2-3 h using dialysis membrane. The concentration of the PAC DNA 
preparation was estimated on a normal 0.8% agarose gel and the integrity of the DNA sample 
was checked by analytical PFGE as described in part 6.2.1.2.3 of Materials and Methods. 
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6.2.1.2. DNA characterization 
 
6.2.1.2.1. Restriction digestion 
The conditions (buffer, temperature) for the digestion reaction were depending on the restriction 
enzyme used and were given by the manufacturer. The reactions were incubated 30 min 
minimum, overnight if preparative. Depending on the final volume of the reaction, 0.5-4 µl of 
enzyme with 10 U/µl were added to the reaction.  
For an analytic digestion reaction of plasmid DNA prepared with the Miniprep protocol as 
described previously, 5 µl of DNA were used in a final volume of 10 µl in the presence of RNase 
A (50 µg/ml). For a Midi or Maxi DNA preparation, 500 ng of DNA were used in a final volume 
of 20 µl (water). For an analytic restriction digestion (Southern blot) of PAC DNA, 3-10 µl of 
DNA (depending on the concentration) were digested overnight. For genomic DNA, 20 µg of 
DNA were digested overnight. 
For a preparative restriction digestion, 2-5 µg of plasmid DNA (or 20-30 µl from a Mini-
preparation) were digested overnight in a final volume of 40-50 µl. Double-digestion reactions 
with two enzymes were performed in the same digestion buffer allowing the digestion of both 
enzymes according to the manufacturer´s instructions. 
 
6.2.1.2.2. Analytical agarose gel electrophoresis 
The analytic and preparative separation of DNA molecules according to their size was performed 
on an agarose gel electrophoresis (126). The agarose concentration of the gel (from 0.7% to 2%) 
depends on the size of the expected DNA fragments. The electrophoresis was run in 1X TAE 
buffer. DNA was then vizualized under UV-light when stained with ethidium bromide (0.5 
µg/ml). 
 
6.2.1.2.3. Analytical PFGE 
The analytical PFGE was performed as described previously for the preparative PFGE, except 
that the gel could be stained with ethidium bromide in order to detect the DNA fragments. 
 
6.2.1.2.4. Southern blot 
After restriction digestion and resolution by gel electrophoresis, the digested DNA was 
transfered on a positively charged nylon membrane and characterized by hybridization with a 
radiolabeled DNA probe. The gel was first depurinated by incubation for 10 min in 0.25 M HCl. 
To denature the DNA in order to get single stranded DNA for the hybridization, the gel was 
incubated 3 times 15 min under shaking in 0.4 M NaOH. At the same time the nylon membrane 
was equilibrated in 20X SCC. The gel was placed on the membrane covered with a dried 
Whatman filter paper and air bubles were removed. Four filter papers previously wet in 20X 
SCC were placed on the gel. Both extremities of the two last filter papers were soaked into a 
cuve containing 20X SCC. The first dried filter paper was soaking up the buffer and at the same 
time the DNA from the gel to the membrane. The buffer was then soaked up by the four upper 
filter papers (downward-blotting). The transfer time was lasting 2 h for plasmid DNA or 
overnight for PAC DNA. After transfer, the membrane was rinced in 1 M NaP buffer to avoid 
the formation of salt cristals. The DNA was then fixed covalently to the membrane by UV-cross 
linking (1200 mJ/cm2) and could then be hybridized. 
 
6.2.1.2.5. Hybridization 
The radiolabeling of the probe (50 ng of a DNA fragment complementary to the sequence to 
recognize) was performed using the random prime labeling method (127). Distilled water was 
added to the DNA preparation to obtain a final volume of 31 µl. After incubation at 95°C for 5 
min, the reagents were added as follows: 2 µl BSA (10 mg/ml), 10 µl 5X OLB-C, 5 µl α-32P-
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dCTP (10 µCi/µl), 2 µl Klenow polymerase (2 U/µl). The reaction was incubated at 37°C for 1 h. 
In order to check for the correct labeling of the probe, a gel chromatography was carried out to 
separate the radioactive labeled DNA from the non-incorporated radioactive dNTPs. NaH2PO4 
pH 3.5 was used as running buffer. Before proceeding to the hybridization, the probe was 
denaturated by incubation at 95°C for 5 min. 
The pre-hybridization was performed by incubation of the Southern blot membrane for 1 h at 
65°C in a hybridization oven in glass cylinders containing some Church buffer. Before adding 
the radioactive probe, the Church buffer was exchanged with a defined volume of buffer (0.1 
ml/cm2 membrane surface) heated at the hybridization temperature. The radioactive probe was 
then added (107 cpm/10-20 ml - monitored with a Geiger counter - for Southern blot on genomic 
DNA, or 5.106-107 cpm/10-20 ml for Southern blots on PAC DNA) and hybridized overnight at 
the hybridization temperature.  
After hybridization, the solution was removed and the membrane washed 4 times (2 times 5 min, 
then 2 times 20 min) with 65°C-heated washing buffer II and dried on a filter paper. The 
membrane was then exposed to autoradiography films (Kodak or Agfa/Fuji) at -80°C for an 
exposure time, which was depending on the signal strength (several hours or days). For 
determination of the transgene copy number by Southern blot, the membrane was exposed to 
Phospho-Imager plates at RT from several hours to overnight. Hybridization signals from the 
Phospho-Imager plates were detected with a FUJIFILM BAS-1800 Phosphor-Imager and 
quantified using the Aida V. 2.0 software, which allows manual baseline substraction of the 
intensity of the wiltd-type band. 
 
6.2.1.2.6. DNA sequencing 
Sequencing of plasmid DNA and PAC DNA was performed by the SeqLab company 
(Sequence Laboratories Göttingen GmbH, Germany). DNA was prepared according to the 
SeqLab´s instructions. 
 
6.2.1.3. Clones screening 
 
6.2.1.3.1. Screening of a genomic PAC library  
A genomic PAC library is made of high-density gridded nylon filters ready for screening by 
hybridization. For the mouse genomic PAC library RPCI21 (RZPD, Germany), which was used 
in the present study and screened for the AQP2 gene, each filter contains 36864 colonies, which 
represent 18432 independent clones that have been spotted in duplicate. The filters were 
hybridized with a radiolabeled cDNA probe for the gene of interest, as described previously. 
After 16-18 h hybridization, the filters were rinced 6 times 10 min with the washing buffer I and 
6 times 10 min with the washing buffer II and then dried. The hybridization signal was detected 
on a Röntgen film after 5 days of exposition. The interpretation of the position of the positive 
clones on the film was performed according to the manufacturer´s instructions and using the 
transparent overlay supplied with the filters as an orientation guide 
(http://bacpac.chori.org/download.htm).  
All clones spotted on the filters were available as transformed bacterial agar cultures. To verify 
the positive clones identified in the genomic PAC library, DNA was isolated, the ends of the 
genomic insert were sequenced and the respective sequences were blasted to the mouse genome 
(www.ensembl.org). 
 
6.2.1.3.2. Dot blot for screening of mouse transgenic founders  
Dot blot allows large-scale identification of transgenic mice. The target DNA (30 µg prepared 
from mouse tail) was fixed to a nylon membrane by using a vacuum dot blot manifold system 
(Schleicher & Schüll, Germany) according to the manufacturer´s instructions. The dot blot 
chamber was assembled with two Whatman filter papers and the nylon membrane, previously 
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wet in water and then 2X SCC, on top. The DNA preparation (27 µl) diluted in 2M NaOH (3 µl) 
and 6X loading buffer (3 µl) was spoted on the membrane, followed by loading of 200 µl of 10X 
SCC for washing. The DNA was transfered to the membrane by the vaccum system. The 
membrane was rinced in 0.4 M NaP for 5 min, dried, and the DNA UV-crosslinked to the 
membrane. After washing of the membrane in 1 M NaP, the hybridization with the radiolabeled 
probe and detection were performed as described in part 6.2.1.2.5.  
 
6.2.1.4. Generation and transformation of recombinant DNA 
Molecules of recombinant DNA were generated by ligation of linear DNA fragments. The linear 
fragments were obtained from restriction digestion of DNA isolated by preparative agarose gel 
electrophoresis as described previously. 
 
6.2.1.4.1. Vector dephosphorylation 
To ligate a DNA fragment into a cloning vector, the vector was linearized by restriction 
digestion and dephosphorylated using the Shrimps alkaline phosphatase (Roche) to avoid any 
religation of the vector. The linearized dephosphorylated vector was purified by agarose gel 
electrophoresis. 
 
6.2.1.4.2. Ligation 
To obtain an efficient ligation reaction, the molar ratio vector:insert has to be 1:3 or 1:4, but can 
vary depending on the size of the insert. The concentrations of the vector and insert preparations 
were estimated according to the volumes and DNA amounts before isolation (using the band 
intensity on the agarose gel) and the ligation reaction processed accordingly. The ligation 
reaction was set up as following: 15 µl of vector + insert (with water if needed), 2 µl of 10 mM 
Li[ATP], 2 µl of 10X ligation buffer, 1 µl of T4 DNA ligase. The reaction was incubated at RT 
for 3-4 h or at 16°C overnight. For each newly prepared, linearized and dephosphorylated vector, 
a control ligation without insert was performed. Indeed, the number of resistant bacterial 
colonies, which grow after transformation in this control condition, gives an estimation of the 
non-linearized or non-dephosphorylated plasmid DNA in the vector preparation. The bacterial 
clones, which grow after transformation in the vector-insert ligation condition, contain the 
recombinant plasmid and not the original vector, only if the number of colonies obtained in the 
vector-insert ligation reaction is higher than that obtained in the control reaction.  
 
6.2.1.4.3. Transformation 
Bacteria, which contain an extragenous plasmid DNA and can replicate, are called competent 
(for a specific transformation method). For the transformation of a ligation reaction, heat-shock 
competent bacteria from the strain E.coli NM554 were used according to the protocol published 
in (126) and were transformed with DNA. Recombinant plasmid DNA was then isolated from 
the bacteria as described in part 6.2.1.1.1 of Materials and Methods. 
 
6.2.2. Polymerase chain reaction (PCR) 
6.2.2.1. Analytic genotyping PCR 
 
To determine the genotype of a mouse, 2 µl of genomic DNA prepared from a piece of tail (as 
described previously) was processed for genotyping PCR on a thermocycler (MWG) using Taq 
polymerase (Roche) in 25 µl reaction volume according to the manufacturer´s instructions.  
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The conditions of the PCRs performed in the present study and the size of the expected amplified 
DNA fragments are presented in the table below: 
 
PCR Primers Conditions PCR products 
MR floxed allele MR flox-7 
MR flox-10 
MR flox-8 
-95°C for 2 min 
-35 cycles  
95°C for 30 s,  
63°C for 2 min,  
72°C for 2 min 
-72°C for 5 min 
-MR wild-type allele: 285 bp 
-MR floxed allele:      335 bp 
-MR null allele:          390 bp 
AQP2Cre or AQP2Cre-
ERT2 transgene 
AQP2-12 
CAMK-2 
AQP2-13 
Same conditions as for the 
MR floxed allele PCR 
except 1 min annealing and 
1 min amplification 
-AQP2 wild-type locus: 150 bp  
-Cre transgene:               310 bp 
Rosa26 reporter 
 
ROSA-1 
ROSA-2 
ROSA-3 
Same conditions as for the 
AQP2Cre or AQP2CreERT2 
transgene PCR 
-Rosa26 wild-type locus: 270 bp  
-Rosa26 mutant:               420 bp 
 
6.2.2.2. Preparative PCR for cloning 
A preparative PCR (to isolate the amplificate) with plasmid DNA or first strand cDNA as 
template was set up on 1-50 ng plasmid DNA (or 2 µl first strand-cDNA) using the Pfu DNA 
polymerase in 50 µl reaction volume according to the manufacturer´s instructions. The PCR 
conditions were as follows: 94°C for 2 min, 20-30 cycles 94°C for 30 s, annealing temperature 
for 30 sec, 72°c for 2 min/kb amplificate length, 72°C for 5 min. 
 
 
6.2.3. Modification of a PAC by homologous recombination in 
E.coli (ET-cloning)  
Recombinant DNA molecules can be generated by homologous recombination in E.coli using 
the ET-cloning method developped in the laboratory of A. Francis Stewart at EMBL 
(Heidelberg, Germany) (83). This method allows the integration of a linear DNA molecule 
flanked by sequences called homology arms into homologous regions in an acceptor vector. In 
the present study, the acceptor vector to recombine was a PAC containing the AQP2 gene and 
the linear DNA molecule to integrate into the PAC was a linear fragment containing the Cre 
recombinase coding sequence flanked by sequences homologous to the AQP2 gene (AQP2Cre 
linear fragment). The PAC was modified in the bacterial DH10B strain delivered by the genomic 
PAC library and containing the PAC. The bacteria were transformed with the ET-plasmid 
expressing the recombinase (128), the recombination induced and the linear fragment 
transformed.  
 
6.2.3.1. Preparation of the linear fragment: PCR amplification of the 
homology arms and cloning into the Cre-containing plasmid 
The homology arms were inserted in the linear DNA by PCR amplification. As described in 
(129), to obtain the best recombination efficiency, the primers for the PCR amplification have to 
be designed so that the homology arms on the linear DNA contain more than 50 bp overlap with 
the homologous regions in the acceptor vector. In the present study, in order to insert by 
homologous recombination in bacteria the sequence coding for the Cre recombinase into the 
PAC harbouring the AQP2 gene (acceptor vector), a 319-bp 5´ homology arm, homologous to 
the 5´ region of the AQP2 gene and containing the ATG at the 3´ end, and a 372-bp 3´ homology 
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arm, homologous to the 3´ region of the AQP2 gene, were amplified by PCR with the AQP2-
5´hom forward and AQP2-5´hom reverse, and withz the AQP2-3´hom forward and AQP2-3´hom 
reverse primers, respectively. The primers were designed in order to introduce restriction sites 
needed for cloning and release of the linear fragment. Two half-restriction sites were introduced 
at the 5´ end of the 5´ homology arm: one EcoRV half-site for analysis of the insert orientation 
after cloning into the pConst plasmid (the second half-site is already present in the pConst 
plasmid) and one PmeI half-site for release of the final construct (the second half-site is present 
in the genomic AQP2 sequence). One XbaI site was introduced at the 5´ end of the 3´ homology 
arm to create after digestion a sticky end compatible with the NheI-digested end of the 5´ 
homology arm-containing pConst (abbreviated p5Const) and not digestable by NheI after 
ligation. At the 3´end of the 3´ homology arm, one NheI site was introduced for the cloning into 
the p5Const, and one PmeI site for the final release. The PCR products were then isolated on an 
agarose gel and purified using the Qiagen method as previously described. Both homology arms 
were then cloned in the Cre-containing plasmid (pConst for the constitutive construct or pIndu 
for the inducible construct) The 319-bp long 5´ homology arm containing the ATG at the 3´ end 
was cloned in front of the Cre coding sequence in the pConst plasmid previously digested with 
EcoRV and dephosphorylated. The 372-bp long 3´ homology arm was digested by XbaI and 
NheI and cloned after the ampicillin resistance cassette in the p5Const plasmid previously 
digested by NheI and dephosphorylated, to obtain the p5Const3 plasmid containing both 
homology arms upstream of the Cre coding sequence and downstream of the ampicillin 
resistance cassette, respectively. The final plasmid harbouring both homology arms (p5Const3 or 
p5Indu3) was linearized by PmeI digestion. 
 
6.2.3.2. PAC modification by homologous recombination in bacteria 
 
6.2.3.2.1. Preparation of competent bacteria containing the PAC and transformation with 
the ET-plasmid 
A 500 ml kanamycin containing-LB medium culture was inoculated from a 2 ml culture of the 
DH10B clones containing the PAC and shaked at 37°C. When the O.D. reached 0.5, the culture 
was cooled down at 0°C for 10 min and centrifuged (3000g, 0°C). The bacterial pellet was 
resuspended in 50 ml of 10% glycerol and centrifuged again. This step was repeated once. The 
bacterial pellet was then resuspended in 300 µl of 10% glycerol, aliquoted in 50-µl aliquots and 
frozen in liquid nitrogen. The competent PAC-containing bacteria were defrozen on ice and 
added to 50-100 ng of ET-plasmid (pR6KBADαβγtetR plasmid). The DNA was transformed in 
the bacteria by electroporation in cooled cuvettes using a Gene-Pulser (Biorad) at 2.30 kV, 25 µF 
and 200 Ω. The bacteria were resuspended in 1 ml of LB medium, shaked at 37°C for 90 min 
and plated on LB-agar plates containing 0.05 mg/ml of tetracyclin and 0.025 mg/ml of 
kanamycin.  
 
6.2.3.2.2. Preparation of competent bacteria containing the PAC and the ET-plasmid and 
transformation with the linear Cre-containing fragment 
The DH10B clones, which contained the modified PAC and the ET-plasmid, were prepared to be 
competent for electroporation as described previously, this time under recombinase (recE) 
induction with arabinose: when the O.D. reached 0.2, 0.2% arabinose was added to the culture to 
induce the expression of recE. Bacteria were then electroporated (2.3 kV, 25 µF, 200 Ω) with 0.3 
µg of the linear Cre-containing fragment (PmeI-digested p5Const3 or PmeI-digested p5Indu3 
plasmids) prepared as described in part 6.2.3.1 of Materials and Methods. After resuspension in 
1 ml of LB-arabinose medium and shaking at 37°C for 90 min, the bacteria were plated on LB-
kanamycin-ampicillin-agar plates and should therefore contain only the modified PAC and not 
the ET-plasmid. This was checked by analytic DNA Mini preparation, Southern blot and DNA 
sequencing. 
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6.2.3.2.3. Removal of the ampicillin resistance cassette 
The linear DNA molecule contains an ampicillin resistance cassette to select efficient 
recombination event. After homologous recombination in bacteria, the modified PAC does not 
need to carry this resistance cassette, which is flanked by FRT sequences. To remove it, a 
plasmid expressing the Flp recombinase (p705-Flp plasmid) was transformed in the bacteria 
containing the modified PAC (128). This was performed by electroporation and by growing the 
bacteria at 30°C in the presence of kanamycin and chloramphenicol (p705-Flp carries a 
chloramphenicol resistance cassette and its replication is temperature-sensitive). The Flp 
expression was induced by growing bacteria in liquid culture at 37°C. The bacteria were then 
plated on LB-kanamycin-agar plates in order to get single clones, which lost the p705-Flp 
plasmid after the transient Flp expression.  
 
6.2.4. RNA analysis 
6.2.4.1. RNA isolation 
 
6.2.4.1.1. From mpkCCDc14  
Total RNA was isolated from mpkCCDc14 cells using the RNeasy Mini kit (Qiagen) essentially 
according to the manufacturer´s instructions with the following modifications. Cells were lysed 
directly in the Transwell filters, described in part 6.2.6, for 4 min at RT in β-mercaptoethanol-
added RLT lysis buffer. Lyzed cells from 2 filters were pooled and either frozen at -80°C or 
processed to the next step. Lysed cells were homogenized by vortexing for 1 min. For the last 
step of the Qiagen RNeasy Mini protocol, the elution was done in 30 µl of DEPC-water. After 1 
min at RT, the Qiagen column was centrifuged (13000 rpm, 1 min) and the eluate was used for a 
second elution step to increase the RNA isolation yield. The RNA amount was determined by 
measuring the O.D. at 260 nm and the quality of the RNA preparation was assessed by using a 
RNA 6000 Micro Labchip (Agilent). The RNA isolation yield reached 10-15 µg RNA for 2 
Transwell filters. 
 
6.2.4.1.2. From microdissected mouse renal tubules 
Mice were deeply anesthetized by ketamine/xylazine (5 mg/kg bodyweight, i.p.). The abdominal 
aorta was exposed and clipped proximal to the renal arteries. A polyethylene catheter was 
inserted into the aorta and the kidneys were perfused by 1 ml supplemented Ringer-type solution 
at 37°C containing collagenase type II (225 U/mg) (Worthington) and protease type XIV (1 
mg/ml) (Sigma), respectively. Ringer-type solution was supplemented with glycine (375 mg/l), 
trypsin inhibitor (48 mg/l), and DNase I (Roche) (25 mg/l). Perfused kidneys were immediately 
removed and sliced (300 µm). Four slices were further incubated for 10 min with gentle shaking 
at 37°C in 2 ml of the enzyme solution. The resulting tubule suspension was sedimented at 4°C, 
washed twice in ice-cold supplemented Ringer-type solution containing albumin (0,5 g/l). After 
resuspension, the tubules were dissected and sorted under a MZ16 stereo-microscope at dark 
field illumination (Leika) at 4°C. In the present study, 50 collecting ducts (cortex and outer 
medulla, ca. 25 µg wet weight) were identified and used for mRNA isolation and further 
processing. The method was adapted from (130). Total RNA was isolated from microdissected 
tubules using the Qiagen RNeasy Micro kit (Qiagen) essentially by the manufacturer´s 
instructions with the following modifications. Microdissected tubules were lysed by adding 5 µl 
of carrier RNA and the appropriate volume of β-mercaptoethanol-added RLT buffer to get a total 
volume of 350 µl. Lysed microdissected tubules were homogenized by vortexing for 1 min and 
RNA isolated as described in the Qiagen RNeasy Micro protocol. For the last step, elution was 
done in 14 µl DEPC-water.  
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6.2.5. Protein analysis 
6.2.5.1. Extraction, fixation and embedding of mouse organs 
 
6.2.5.1.1. Paraffin embedding 
Mice were killed by CO2, organs extracted and fixed overnight in 4% PFA at 4°C. Organs were 
washed 2 times 30 min in PBS at RT and then dehydrated through an increasing ethanol 
gradient: 2 times 30 min and 1 time 1 h in 70% ethanol, 1 h min in 85% ethanol, 1 h in 95% 
ethanol, and 3 times 1 h in 100% ethanol. The dehydrated organs were incubated in small glass 
cuvettes 2 times 30 min in xylol and overnight in fresh xylol. The organs were heated in xylol at 
60°C for 30 min, xylol was then replaced with warm paraffin, which was exchanged every hour 
for 4 times. Organs were in this way impregnated with paraffin and could be embedded in small 
plastic cuvettes. After air-drying for 1 h, embedded organs were stored at 4°C. 
 
6.2.5.1.2. Tissue-Tek embedding for cryosections 
Mice were killed by CO2, organs extracted, put in small plastic cuvettes containing Tissue-Tek 
and directly placed on a dried ice/ethanol bath for freezing before storage at -20°C. 
 
6.2.5.2. Sectioning of mouse organs 
Paraffin sections, of 6-µm thickness (equivalent to the thickness of a cell nucleus) for 
immunohistochemistry and immunofluorescence or of 3-µm thickness for histology, were 
obtained using a microtome (Leica). Sections were put on Superfrost Plus glass slides (Roth) 
coated with Tespa (Sigma),  fixed to the slide by incubation overnight at 56°C and stored at RT. 
For Rosa26 mouse reporter assays, cryosections of 10-µm thickness were obtained using a 
Cryostat (Leica), put on Superfrost Plus glass slides (Roth) and stored at -20°C. 
 
6.2.5.3. Hematoxylin-Eosin staining 
Paraffin sections were deparaffined 2 times 5 min in xylol and rehydrated through a decreasing 
ethanol gradient (100%, 95%, 85%, 70%, distilled water, eachtime 2 times 5 min). Sections were 
stained with Hemalin (Meyer), washed with distilled water and 25% HCl / 70% ethanol and 
differentiated in running tap water. Sections were then counter-stained with Eosin for 1 min, 
washed in distilled water and dehydrated through an increasing ethanol gradient. After a wash in 
xylol, sections were embedded in Eukitt (O. Kindler GmbH & Co, Germany). 
 
6.2.5.4. Immunohistochemistry on paraffin sections 
Paraffin sections were deparaffined 2 times 5 min in xylol and rehydrated through a decreasing 
ethanol gradient (100%, 95%, 85%, 70%, distilled water, eachtime 2 times 5 min). After 
blocking of endogenous peroxidase activity by incubation in 3% H2O2 for 10 min, sections were 
microwave-treated (800 W for 2 min, 360 W for 8 min) in Antigen-Retrieval buffer (DCS, 
Hamburg, Germany). After cooling-down at RT, sections were washed in PBS and incubated for 
30 min with blocking solution (5% NSS in PBS). Sections were then incubated overnight at 4°C 
with the primary antibody diluted in PBS (or incubated with PBS as control). After washing in 
PBS, sections were incubated 30 min with the appropriated biotinylated secondary antibody. The 
avidin-biotin complex (ABC)-peroxidase system (Vectastain, Vector Laboratories) was used to 
detect the staining. The 3,3'-diaminobenzidine (DAB) substrate (Sigma Chemicals) was used to 
give a brown precipitate. Sections were then washed in distilled water. For single staining, 
sections were dehydrated through an increasing ethanol gradient, washed in xylol and embedded 
in Eukitt. For double staining, sections were incubated overnight with the second primary 
antibody, then with the corresponding secondary antibody and stained as described above for the 
first primary antibody. 
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Double immunohistochemistry for MR and AQP2 was performed with the following primary 
antibodies: a monoclonal MR antibody raised against the peptide comprising amino acids 1-18 of 
the rat MR N-terminus (131) diluted 1:20 and an affinity purified goat polyclonal antibody raised 
against the C-terminus of the human AQP2 (Santa Cruz Biotechnology, USA) diluted 1:100. A 
goat anti-mouse biotinylated antibody (Dianova-Jackson Laboratories, Germany) diluted 1:150 
and a swine anti-goat biotinylated antibody (Cedarline Laboratories, Canada) diluted 1:80 were 
used as secondary antibodies. MR staining was revealed with a horseradish peroxidase-
streptavidin complex (SA-5004, Vector Laboratories, USA) diluted 1:200 using 3-Amino-9-
ethylcarbozole (SK-4200, Vector Laboratories) as substrate to give a brown substrate reaction. 
AQP2 staining was revealed with an alkaline phosphatase-streptavidin complex (Vector 
Laboratories) diluted 1:200 using the alkaline phosphatase substrate kit III (SV-5300, Vector 
Laboratories) to give a blue substrate reaction. 
 
6.2.5.5. Immunofluorescence on paraffin sections 
Paraffin sections were processed exactely as described for immunohistochemistry, except that all 
incubations were done at 4°C in the dark, that the secondary antibodies were conjugated to 
fluorophores and that sections were mounted in Fluoromount-G (Southern Biotechnology 
Associates, Burmingham, USA). 
Double immunofluorescence for AQP2 and Cre was performed with the following antibodies: 
goat anti-AQP2 diluted 1:50 and rabbit anti-Cre (132) diluted 1:200 as primary antibodies, and 
Alexa 488-conjugated donkey anti-goat IgG and Alexa 594-conjugated goat anti-rabbit IgG 
(Molecular Probes, USA) both diluted 1:100 as secondary antibodies. 
  
6.2.5.6. Immunofluorescence on cryosections  
Cryosections were air-dried, hydrated in PBS and processed for immunofluorescence as 
described for paraffin sections. 
Immunofluorescence labelings for MR, calbindin D28k, αENaC, TSC and Cre were performed 
as described in (99) on serial cryosections with the following primary antibodies: mouse anti-MR 
diluted 1:20, mouse anti-calbindin D28k (Swant, Switzerland) diluted 1:20000, rabbit anti-
αENaC (99) diluted 1:500, rabbit anti-TSC (86) diluted 1:10000, rabbit anti-Cre and goat anti-
AQP2 both diluted 1:1000. Binding sites of the primary antibody were detected using 
horseradish peroxidase (HRP)-conjugated sheep anti-mouse IgG (Amersham) revealed with a 
tyramide-signal amplification kit (PerkinElmer, Switzerland), FITC-conjugated goat anti-mouse 
IgG (Jackson ImmunoResearch, USA) diluted 1:40, Cy3-conjugated goat anti-rabbit IgG 
(Jackson ImmunoResearch) diluted 1:1000, and Cy3-conjugated donkey anti-goat IgG (Jackson 
ImmunoResearch) diluted 1:1000, respectively.  
 
6.2.5.7. LacZ staining on cryosections for Rosa26 mouse reporter 
assays 
Cryosections of organs from mice carrying the Rosa26 reporter allele were air-dried at RT for 5 
min and at 37°C for 2-3 min, fixed at RT for 5 min in the fixation solution, washed 3 times 5 min 
in the washing solution on ice, and incubated in the staining solution at 37°C for 4-24 h 
(depending on staining intensity) in the dark. After staining, sections were rinced in PBS, 
dehydrated through an increasing ethanol gradient, washed in xylol and embedded in Eukitt (O. 
Kindler GmbH & Co, Germany). 
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6.2.6. mpkCCDc14 cell culture 
6.2.6.1. Cell culture and passage 
Cells were routinely grown in 25-cm2 culture flasks (Corning) at 37°C, 5% CO2, 95% air 
atmosphere in standard culture medium. The medium was changed every 2 days. Confluent cells 
could be recognized by the appearing of domes observed under the microscope (92). To split the 
cells, culture medium was removed from the 25-cm2 flask and cells were incubated with 3 ml of 
trypsine-EDTA for 20 min at 37°C. Trypsine action was stopped by adding 5 ml of fresh 
standard culture medium. Trypsinized cells were centrifuged in a Falcon tube (1000 rpm, 5 min), 
the supernatant was removed and the pellet resuspended in 7 ml of medium. For a 25-cm2 flask, 
0.5 ml of resuspended cells was diluted in 5 ml medium.  
 
6.2.6.2. Cells freezing  
Culture medium was removed from the 25-cm2 flask and cells were incubated with 3 ml of 
trypsine-EDTA for 20 min at 37°C. Trypsine action was stopped by adding 5 ml of fresh 
standard culture medium. Trypsinized cells were centrifuged in a Falcon tube (1000 rpm, 5 min), 
the supernatant was removed and the pellet resuspended in 1.5 ml of FCS / 10% DMSO. 
Resuspended cells were transfered into cryovials and incubated at 4°C for 30-60 min, then at -
80°C for 18-24 h before frozing in liquid nitrogen. 
 
6.2.6.3. Cells defreezing 
The day before defreezing, collagen-coated 25-cm2 flasks were prepared with 400 µl of 2% 
collagen (in 60% ethanol) per flask, which was drying overnight under the hood. Cells were 
defrozen at RT under the hood and centrifuged (1000 rpm, 5 min). The supernatant was 
removed, the pellet resuspended in 5 ml of 10% FCS-containing standard culture medium and 
the resuspended cells plated in the collagen-coated 25-cm2 flasks. The medium was replaced 
after 24 h and then after 48 h. 
 
6.2.6.4. Cells treatment 
Experiments were performed on confluent mpkCCDc14 cells seeded on semi-permeable 
polycarbonate Transwell filters (0.4 µm pore size, 1-cm2 growth area, Corning Costar, USA). For 
a 12-well Transwell filter plate used for the short-circuit current studies, 300 µl of resuspended 
cells were diluted in 300 µl of medium and plated on the Transwell membrane in the upper 
compartment of the insert. The lower compartment was filled with 1.5 ml of medium. Cells were 
grown in standard culture medium until confluence (day 6 after seeding), placed in hormone-free 
medium for 18 h, and then in hormone-free and serum-free medium for additional 18 h. Cells 
were then treated with vehicle or aldosterone (10-6 M) for 4 h in the presence or absence of 
amiloride (5.10-6 M), RU486 (10.10-6 M) or spironolactone (10.10-6 M) (added to both apical and 
basal sides of the filters). For the microarray experiment, cells were treated with vehicle or 
aldosterone (10-6 M) for varying times (1 h, 2 h or 4 h). 
 
6.2.6.5. Short-circuit current studies 
The sodium transport capacity of the mpkCCDc14 cells was assessed by the short-circuit current 
(Isc), calculated from the transepithelial votage UT and resistance RT using Ohm´s law. UT and RT 
were measured on cells grown on Transwell filters using dual Ag/AgCl electrodes connected to a 
Millicell-Electrical Resistance System (Millipore, Germany). Experiments were always 
performed on sets of untreated or treated cells from the same passage number to avoid 
interpassages variations.    
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6.2.7. Gene expression analysis 
6.2.7.1. Microarray analysis on mpkCCDc14 cells  
 
6.2.7.1.1. RNA isolation 
Total RNA was isolated from mpkCCDc14 cells using the Qiagen RNeasy Mini kit as described 
in part 6.2.2.1.1. Ethanol precipitation was performed on 10 µg of RNA by adding 1/10 volume 
of 3 M NaOAc pH 5.2, 2.5 volumes of 100% ethanol, and 1.0 µl of Pellet Paint (Novagen). After 
precipitation at -20°C for 1 h, the reaction was centrifuged (>12000 g, 30 min, 4°C), the pellet 
washed twice with 80% ethanol and resuspended in 10 µl of DEPC-water.  
 
6.2.7.1.2. Double-stranded cDNA synthesis 
First and second cDNA strand synthesis was performed on 10 µg of total RNA from aldosterone- 
or vehicle-treated mpkCCDc14 cells using Invitrogen reagents according to the protocol provided 
in the Affymetrix GeneChip Expression Analysis Manual with the following modifications. The 
first strand DNA synthesis reaction was pocessed for 1 h at 42°C using the SuperScript II reverse 
transcriptase (Invitrogen Life Technologies). The second strand cDNA synthesis was performed 
using 10 U of E.coli DNA ligase, 10 U of E.coli DNA polymerase I,  and 2 U of E.coli RNase H 
in a reaction containing 5X second strand cDNA buffer and 10 mM dNTPs. The reaction was 
proceeded at 16°C for 2 h before 2 U of T4 DNA polymerase were added, the reaction allowed 
to proceed at 16°C for 5 min, and terminated by adding 0.5 M EDTA. Double stranded cDNA 
was then cleaned-up using Phase Lock Gel (PLG) tubes (Eppendorf) previously centrifuged 
(>12000 g, 20-30 s). An equal volume of phenol:chloroform:isoamyl alkohol (IAA) (25:24:1, 
saturated with 10 mM Tris-HCl pH 8.0, 1 mM EDTA) was added to the final cDNA preparation. 
After vortexing briefly, the entire cDNA / phenol:chloroform:IAA mixture was transfered to the 
PLG tube, centrifuged at full speed for 2 min, and the aqueous upper phase was transfered to a 
fresh 1.5 ml tube. The cleaned cDNA was then ethanol-precipitated by adding 0.5 volume of 7.5 
M NH4OAc and 2.5 volumes of 100% ethanol. After precipitation at -20°C for 1 h, the reaction 
was centrifuged (>12000 g, 30 min, 4°C), the pellet washed twice with 80% ethanol and 
resuspended in 12 µl of DEPC-water. 
 
6.2.7.1.3. Biotin-labeled cRNA synthesis 
The synthesized cDNA (5 µl) was in vitro transcribed (IVT) using the T7 RNA polymerase from 
the ENZO BioArray High Yield RNA Transcript Labeling Kit (Enzo, USA) according to the 
manufacturer´s instructions to obtain a biotin-labeled cRNA. Half of the IVT products was then 
cleaned-up using Qiagen RNeasy columns according to the manufacter´s instructions, except for 
the last step where the elution was done in 35 µl of DEPC-water, and the eluate re-used for a 
second elution step to increase the cRNA yield. Labeled cRNA quantification was performed by 
measure of the O.D. at 260 nm.  
 
6.2.7.1.4. cRNA fragmentation 
The random fragmentation of cRNA was performed on a minimum of 0.6 µg/µl of adjusted 
cRNA. The adjusted cRNA yield was calculated according to Affymetrix instructions as follows: 
adjusted cRNA yield = mRNA – (total RNAi)(y), with mRNA = amount of cRNA measured 
after IVT (µg) (described in part 5.2.7.3.3), total RNAi = starting amount of total RNA (5 µg), 
and y = fraction of cDNA used in IVT (5/12). The reaction was carried out at 95°C for 35 min 
with 8 µl of 5X fragmentation buffer in a final volume of 40 µl (adjusted with RNase-free 
water). Fragmented cRNA as well as unfragmented cRNA, cDNA and unpurified cRNA were 
checked for quality by gel electrophoresis (1% agarose gel) or using LabChips from Agilent. 
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6.2.7.1.5. Target hybridization on microarray 
Hybridization, staining and scanning of the GeneChip Mouse Expression Arrays MOE 430 
(Affymetrix) were performed on the Affymetrix platform at the Medical Research Center of the 
University Hospital Mannheim (Prof. Norbert Gretz) according to the GeneChip Expression 
Analysis Manual provided by Affymetrix.  
 
6.2.7.1.6. Normalization and statistical analysis 
Quality and normalization of the arrays were performed using the GC-RMA software (version 
1.1.0) of the Bio-Conductor package (http://www.bioconductor.org) (133). The uniformity and 
the intensity of labeling were checked. Global scaling was applied to all arrays such that the 
mean intensity of each array was equivalent, and a quantitative assessment of signal-to-noise 
ratio and of the median intensity was also performed. Only those arrays having reasonable 
quality were used for further analysis. Statistical analysis of microarray data was performed 
using the GC-RMA and the SAS Microarray Solution (from SAS) softwares. Both factors 
“treatment” (aldosterone or vehicle) and “time of treatment” (1 h, 2 h or 4 h) were included in 
the analysis. For each array, gene expression values were determined for each gene. Comparison 
of the gene expression values between aldosterone-treated and untreated cells (used as baseline) 
resulted in a list of differentially expressed genes for each time-point and for each software. 
Mutual exclusion of the genes predicted by both GC-RMA and SAS Microarray Solution 
softwares was performed and only genes found as aldosterone-regulated by both softwares were 
further analyzed. 
 
6.2.7.2. Quantitative real-time PCR on RNA isolated from 
microdissected mouse renal tubules 
A reverse transcriptase reaction using the Superscript II enzyme (Invitrogen) and oligo(dT)12-18 
was carried out on 10 µl of total RNA prepared from microdissected mouse renal tubules to 
obtain a first strand cDNA according to the manufacturer´s instructions. Gene expression 
quantification was performed using the TaqMan Gene Expression Assays kit (Applied 
Biosystems) with the TaqMan Universal PCR Master Mix / No AmpErase UNG reagents 
(Applied Biosystems) according to the manufacturer´s instructions. Primers and TaqMan probes 
were designed and provided by Applied Biosciences. The HPRT gene, which is constitutively 
expressed in mouse kidney and whose expression was not influenced by the mutation in 
MRAQP2Cre mice, was used as endogenous control. For a given target gene, the gene expression 
relative to HPRT expression was determined as 2(HPRT Ct – target gene Ct), where Ct is the first cycle at 
which the reporter signal significantly exceeds the baseline signal. For each target gene, each 
PCR reaction was performed on RNA isolated from several mice and averaged to obtain a mean 
Ct value. Real time PCR reactions were performed on a CHROMO 4 Continuous Fluorescence 
detector (MJ Research) and data were analyzed using the Opticon Monitor 3 software (MJ 
Research). 
 
 
6.2.8. Generation of transgenic mice 
6.2.8.1. DNA preparation 
Preparation of PAC DNA was performed according to (98) and as described in part 6.2.1.1.1 of 
Materials and Methods.  
 
6.2.8.2. DNA microinjection in mouse oocytes 
The microinjection of the DNA in oocytes was performed according to (123). Superovulated 
fertilized FVB/N females were used as source of oocytes. Females were bred with FVB/N males 
and checked for vaginal plug on the day before injection. To induce superovulation, females 
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were injected i.p. with PMS-gonadotropin (Sigma) 3 days before the experiment and with 
chorion-gonadotropin (Sigma) 1 day before the experiment. Females were killed by cervical 
dislocation, the oviducts were removed and transfered to 37°C-heated M2-medium. Oocytes 
were isolated and cumulus cells surrounding the oocytes removed by hyaluronidase treatment 
(100 mg/ml in M2-medium). Oocytes were then rinced with M2-medium in a glass pipette, 
transfered in M16-medium and stored at 37°C, 5% CO2. To proceed to the microinjection, 30-50 
oocytes were transfered in an injection seringe containing some M2-medium under the 
microscope with two micromanipulators setups connected to an hydrolic control system 
(Eppendorf femtoJet). Oocytes were held in place with a blunt holding pipette and the tip of the 
injection needle was filled with a solution containing the transgenic DNA (1-1.5 ng) prepared 
and purified as described in part 6.2.4.1. The DNA was injected into one of the pronuclei, 
usually the larger male one. After injection, oocytes were incubated in M16-medium for 2 h at 
37°C, 5% CO2 and checked for vitality under the microscope. The abdominal cavity of 
anesthezied pseudopregnant FVB/N females was opened and 20-30 transgenic oocytes were 
injected in the oviducts with a thin transfer canule. The lesion of the abdominal cavity was then 
closed with a clamp. Eighteen days after the surgery, FVB/N females give birth, and 10 to 30% 
of the born mice should be transgenic (hemizygous). They were checked for the presence of the 
transgene by genotyping PCR and dot blot on tail DNA.  
 
6.2.8.3. Establishment of AQP2Cre and AQP2CreERT2 transgenic 
mouse lines and generation of MRAQP2Cre mutant mice 
AQP2Cre and AQP2CreERT2 transgenic founder mice were bred to C57Bl/6 mice to generate 
different constitutive or inducible Cre transgenic mouse lines, respectively. The constitutive 
renal principal cell-specific MR mutant (MRflox/flox//AQP2Cre abbreviated as MRAQP2Cre) mice 
and their control (MRflox/flox) littermates were obtained by breeding MRflox/flox with 
MRflox/wt//AQP2Cre mice. The MRflox allele was generated as reported previously (82). The 
genetic background of the mice used in this study was a mixture of FVB/N and C57Bl/6.  
 
6.2.9. Metabolic balance studies 
6.2.9.1. Collection of urine and plasma samples and determination of 
food and water consumption  
Two-month old mice were fed in their homecage either with a standard diet (0.18% sodium; 
ssniff GmbH, Soest, Germany) or with a low-sodium diet (<0.05% sodium; ssniff GmbH, Soest, 
Germany). Bodyweight measurement and blood and urine sampling were always performed in 
the morning between 9 a.m. and 11 a.m. Mice were placed in mouse metabolic cages for 24 
hours to determine water and food consumption and to collect urine. For time-course analysis of 
renal sodium exretion under low-sodium diet, mice were placed in metabolic cages for 5 days. 
Urine volume, urinary sodium concentration, bodyweight and food and water consumption were 
determined every 24 hours. Blood samples were collected from the orbital venous plexus under 
anesthesia with CO2 or decapitation. Blood was collected in sodium/EDTA-coated tubes for 
plasma aldosterone determination and in Li/heparin-coated tubes (Sarstedt AG & Co, Germany) 
for plasma electrolyte measurements.  
 
6.2.9.2. Hormones and metabolites analysis 
Plasma and urinary creatinine concentrations as well as plasma sodium and potassium 
concentrations were measured on a Hitachi 911 autoanalyser (Roche Diagnostics, Germany) at 
the Medical Research Center of the University Hospital Mannheim (Prof. Norbert Gretz). 
Urinary sodium was measured using the EML100 System 625 (Radiometer, Germany) at the 
  Materials and methods 
 74 
Medical Research Center, Mannheim. Aldosterone was measured by radioimmunoassay (Coat-a-
Count; Diagnostics Products Inc., USA). 
 
6.2.9.3. Determination of the glomerular filtration rate (GFR) 
Renal creatinine clearance was measured over 24 hours and the GFR was calculated as: urine 
flow * [urine creatinine] / [plasma creatinine]. 
 
6.2.10. Determination of ENaC and TSC activity 
6.2.10.1. Determination of ENaC activity in kidney 
Mice were injected s.c. with amiloride 5 mg/kg bodyweight (29, 30) in 100 µl of isotonic saline 
during low-sodium diet. Urine was collected over 3 h before amiloride treatment and within 3 h 
after injection. Before each 3-h period, the bladder was emptied by forced voiding achieved 
through placing mice on a cold metalic plate. Blood samples were then collected as previously 
described.  
 
6.2.10.2. Determination of ENaC activity in colon 
Colonic transepithelial potential difference was measured in vivo in anesthetized mice (1.5% 
isoflurane). A perforated, double-barreled flexible polyethylene tube (O.D. 1 mm) was inserted 
into the rectum at a length of 12 mm and perfused with Ringer-type solution in the presence or 
absence of amiloride (50 µmol/l) at 37°C with a flow rate of 0.5 ml/min. The electrical potential 
of this tube was measured via Ag/AgCl electrodes using an UPG1 high input resistance 
differential amplifier (www.ad-elektronik.net). The reference electrode was inserted under the 
skin. The method was adapted from (136). 
 
6.2.10.3. Determination of TSC activity 
Mice were injected s.c. with thiazide 20 mg/kg bodyweight in 100 µl of isotonic saline during 
low-sodium diet. Urine and blood samples were collected as previously described. 
 
6.2.11. Statistics 
All measurements are presented as mean values ± SEM. The data were analyzed using unpaired 
two-tailed Student´s t-test, mutants versus controls if not stated otherwise. 
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9. ABBREVIATIONS 
 
A  Ampere 
ABC  avidin-biotin complex 
ACE  angiotensin-converting enzyme 
AIP  aldosterone-induced proteins 
AIT  aldosterone-induced transcripts 
AME  apparent mineralocorticoid excess  
AQP2  aquaporin 2 water channel 
AR   androgen receptor  
ART  aldosterone-repressed transcripts 
ASDN  aldosterone-sensitive distal nephron 
ATP  adenosine triphosphate 
 
bp  base pair 
BSA  bovine serum albumine 
BW  bodyweight 
 
°C  Celcius degree 
CD   collecting duct 
CD28K calbindin D28k 
cDNA  complementary DNA 
Ci  Curie 
CNT  connecting tubule 
Cpm   count(s) per minute  
Cre-loxP Cre recombinase-loxP site recombination system 
 
DAB  3,3´diaminobenzidine 
dATP  deoxyadenosine triphosphate 
DBD  DNA-binding domain 
DCT  distal convoluted tubule 
dCTP  deoxycytidine triphosphate 
DEPC  diethylpyrocarbonate 
dGTP   deoxyguanosine triphosphate 
DMEM  Dulbecco´s modified eagle medium 
DMSO dimethylsulfoxide 
DNA  desoxyribonucleic acid 
DNase  desoxyribonuclease 
dNTP  desoxyribonucleotide triphosphate 
DSIP1  delta sleep inducing peptide 1 (glucocorticoid-induced leucine zipper protein) 
DTT  dithiothreitol 
DUSP6  dual specificity phosphatase 6 
 
EDTA  ethylenediaminetetraacetic acid 
EGF  epidermal growth factor 
ENaC  epithelial sodium channel 
ER  estrogen receptor  
ERT2  estrogen receptor two point-mutated ligand-binding domain  
ES   embryonic stem (cell) 
  Abbreviations 
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FC  fold change 
FCS  fetal calf serum 
FITC  fluorescein isothiocyanate 
Flp  FRT site-specific flippase recombinase 
FRT  Flp recombination target 
 
g  gram 
g   acceleration of gravity 
GC-RMA GC content-based robust multi-array average  
GILZ  glucocorticoid-induced leucin zipper protein 
GR  glucocorticoid receptor  
GRE  glucocorticoid response element 
GTP  guanosine triphosphate 
 
h  hour 
Hoxb7  homeobox B7 
HPRT  hypoxanthine guanine phosphoribosyl transferase 
HRP  horseradish peroxidase 
11β-HSD2 11β-hydroxysteroid dehydrogenase type 2 
 
IAA  isoamyl alcohol  
IgG  immunoglobulin G 
i.p.  intra-peritoneal  
Isc   short-circuit current 
IVT  in vitro transcription 
 
JGC  juxtaglomerular cell 
 
kb   kilobase 
Kd  dissociation constant  
kg  kilogram 
kV  kilovolt 
 
l   liter 
LacZ  β-galactosidase gene  
LB  Luria Bertani (medium) 
LBD  ligand-binding domain 
 
M  molar 
mg   milligram 
min  minute 
mJ  millijoule 
ml  milliliter 
mmol  millimol 
MOE   mouse expression (Affymetrix microarray) 
mpkCCDc14 mouse pyruvate kinase promoter cortical collecting duct cell line (clone 14) 
MR  mineralocorticoid receptor 
mRNA messanger ribonucleic acid 
µF   microfarad 
µl  microliter  
  Abbreviations 
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n   number 
Na+-K+-ATPase sodium-potassium-adenosine triphosphatase  
Nedd4-2 neural precursor cell-expressed developmentally downregulated gene 4-2  
ng  nanogram 
NID  non ionic detergent (buffer) 
NLS  nuclear localization signal  
nm  nanometer 
nM  nanomolar 
NR  nuclear receptor 
NSS  normal sheep serum 
 
OD  optical density  
Ω  Ohm 
 
P  p-value (Student´s test) 
PAC  P1-derived artificial chromosome 
PBS   phosphate-buffered saline 
PCR  polymerase chain reaction 
PFA   paraformaldehyde 
PFGE  pulsed field gel electrophoresis   
PHA1  pseudohypoaldosteronism type 1 
PIM3  proviral integration site 3 (serine/threonine-protein kinase 3) 
PMS  pregnant mare serum 
PR  progesterone receptor 
 
RAAS  renin-angiotensin-aldosterone system 
RNA  ribonucleic acid 
RNase  ribonuclease 
rpm  rotation(s) per minute 
RT   transepithelial electrical resistance  
RT  room temperature 
RT-PCR real time polymerase chain reaction 
 
s  second 
SGK1  serum- and glucocorticoid-induced kinase 1 
s.c.  sub-cutaneously  
 
TAE  tris-acetate buffer  
TAL  thick ascending limb  
TE  tris-ethylenediaminetetraacetic acid 
Tespa   3-aminopropyltriethoxysilane 
TSC  thiazide-sensitive sodium chloride cotransporter 
 
U   enzymatic unit 
USP2  ubiquitin-specific protease 2 
UT   transepithelial voltage 
UV   ultraviolet 
 
V  volt 
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W  watt 
Wt  wild-type 
 
X-gal  5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (β-galactosidase substrate) 
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